<?xml version="1.0" encoding="UTF-8"?>
<studies>
  <study>
    <criteria>
      <criterion type="exclusion" id="3420">
        <text>- Cardiac arrhythmias requiring anti-arrhythmic therapy other than beta blockers or digoxin.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="6941">
        <text>- diabetes mellitus</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="13702">
        <text>- A primary active mental illness diagnosis other than schizoaffective disorder</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="14640">
        <text>- Platelet count ≥ 100 x 109/L (&gt;100,000 per mm3)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="22403">
        <text>- Too large to fit in the magnet (BMI &gt;= 40, approx.)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="24263">
        <text>- Has known hypersensitivity to pembrolizumab and/or epacadostat or any of their excipients</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="29709">
        <text>- History of solid organ transplantation or collagen vascular disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="33570">
        <text>- at least one prescription claim for any medication in the pre- and post-index period (proxy for continuous enrollment)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="39119">
        <text>- Healthy adult volunteers, male or female, ages between 20 and 40 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="39217">
        <text>- facial trauma or burns that might interfere with the esophageal catheter placement</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="43547">
        <text>- No prior radiotherapy for colorectal cancers including in the neoadjuvant or adjuvant setting within 12 months of development of metastases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="44094">
        <text>- Sub-retinal fibrosis in the study eye</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="47631">
        <text>- Evidence of bleeding diathesis or coagulopathy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="51067">
        <text>4. BMI (body mass index) equal to or greater than 19</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="52224">
        <text>20. Suprax (cefixime)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="52799">
        <text>1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="53798">
        <text>OR</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="57907">
        <text>- any current serious disorders determined to be clinically significant to the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="59648">
        <text>- Adult patients with advanced CTCL</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="60279">
        <text>- Previous adjuvant therapy with capecitabine+platinum</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="62543">
        <text>- Malarial hepatopathy, enteric hepatitis, alcoholic hepatitis, or ischemic hepatitis.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="70643">
        <text>5. An expected survival, in the opinion of the investigator that would not permit a sufficient observation period for evaluating ON 01910.Na.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="76206">
        <text>- 12 months of spontaneous amenorrhea;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="80675">
        <text>- Chronic, stable phase of recovery (&gt;6 months from last post-concussive event)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="80740">
        <text>- Absolute neutrophil count (ANC) &gt;= 1000/mm^3 independent of growth factor support</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="82311">
        <text>- The subject has had a blood transfusion during the current pregnancy</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="85956">
        <text>- Willing to adhere and comply to the protocol requirements as evi-dence by written informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="89574">
        <text>- current or ex-smokers with a smoking history of at least 10 pack-years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="90316">
        <text>- Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="92281">
        <text>6. Subject at an immediate need of transfusion or with a Hb &lt;8 g/dL or with a Hb &gt;15 g/dL.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="92362">
        <text>8. Participation in another clinical study with a non-biologic investigational product or new formulation of a marketed non-biologic drug within 3 months prior to the screening visit.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="93859">
        <text>- written consent</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="98571">
        <text>1. More than two moderate/severe IPF exacerbations within the past year Exacerbation is defined as worsening of two or more of the following major symptoms: dyspnea, sputum volume, sputum purulence OR worsening of any one major symptom together with at least one of the following additional symptoms: sore throat, colds (nasal discharge and/or nasal congestion), fever &gt; 37.5 ° C without any explained cause, increased cough, increase wheeze.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="105249">
        <text>- Ability to complete follow-up period of 180 days after final study vaccination as required by the protocol</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="132912">
        <text>4. Have measurable disease based on RECIST v1.1. for solid tumors</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="138376">
        <text>- Adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="142364">
        <text>- Active Iritis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="143462">
        <text>1. Any biopsy-proven HSIL partially outside of the ETZ (for example, an HSIL lesion with extension to the perianal skin)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="147214">
        <text>8. Life expectancy less than 12 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="151461">
        <text>- Patient has sufficient stored T cell product to manufacture appropriate doses of T-APCs</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="153547">
        <text>- Keratolytic-containing therapeutic products or medicated or irritant topical salves within two weeks of Visit 1/Baseline, including, but not limited to, alpha hydroxy acids (e.g., glycolic acid, lactic acid etc. &gt;5%), beta hydroxy acid (salicylic acid &gt;2%), and urea &gt;5%;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="156444">
        <text>- Currently not involved in any other weight loss program,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="160624">
        <text>13. Patients with hiatal hernia and full stomach patients.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="162458">
        <text>- The subject is known to be positive for HepBsAg, or HCV RNA.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="162671">
        <text>- Currently live within the United States</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="173334">
        <text>- Patient who is 20 years old or over</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="176409">
        <text>- Clinically normal baseline haematology, clinical chemistry, and urinalysis values</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="178510">
        <text>- Written informed consent to participate in the study</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="179747">
        <text>- Agrees to return for follow-up visit and willing to provide an address and/or telephone number for purposes of follow-up.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="183972">
        <text>8. serum creatinine below 1.7 mg/dl in female and 1.8 mg/dl in males;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="185577">
        <text>- Psychologically incapable of undergoing BMT with associated strict isolation or documented history of medical non-compliance.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="188522">
        <text>10. Have a medical condition that would, in the opinion of the study physician, make participation medically hazardous.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="193668">
        <text>17. At the MTD expansion phase of the protocol, all patients must have fine needle aspirate (FNA) biopsiable disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="196061">
        <text>18. Current alcoholism, and/or any known current addiction to pain medications</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="196375">
        <text>- luteinizing hormone releasing hormone (LHRH) analogues</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="196388">
        <text>12. Any condition that impairs patient's ability to swallow whole pills.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="196955">
        <text>- HER2-negative patients (HER2 1+ or negative, or HER2 2+ and FISH negative)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="200237">
        <text>PRIOR CONCURRENT THERAPY:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="201212">
        <text>4. Documented reversibility of ≥15% in FEV1 in the screening phase.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="202292">
        <text>- History of seizures, strokes, degenerative neurological disease, fibromyalgia, diabetic neuropathy, thyroid dysfunction, hypotension, clinically significant arthritis or musculoskeletal disorder.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="203650">
        <text>ii. Or possession of two or more of the following minor criteria:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="204607">
        <text>Subjects will be ineligible to participate in the study if they meet any of the following criteria:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="212334">
        <text>9. Willing and able to provide written informed consent.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="213238">
        <text>- Cardiogenic shock</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="215122">
        <text>2. Prior therapy with sunitinib or anti-PD-1 or anti-PDL-1 antibodies (pembrolizumab, nivolumab, etc.) Prior therapy with other KIT inhibitors (dasatinib, nilotinib, imatinib, etc.) allowed but results from these patients will be analyzed separately.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="218026">
        <text>- Planned primary unilateral THA or TKA</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="218515">
        <text>- No clinically significant deviation outside the normal ranges for blood pressure and pulse measurements</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="225297">
        <text>- Same as exclusion criteria for HIV negative subjects with known subclinical atherosclerosis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="231719">
        <text>- Category II or III fetal heart rate</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="238081">
        <text>Age 18-70 years. Kellgren-Lawrence grade 1 - 4 evaluated on x-ray or ICRS grade 2-4 evaluated on MRI.</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="244895">
        <text>- Abnormal liver function at Screening:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="247438">
        <text>- Subjects must be in good general health as assessed by the Investigator</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="250327">
        <text>1. Major surgery in the previous month</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="253987">
        <text>systemic infections, psychiatric or metabolic disorders, known food allergies or intolerances related to the products used in the study (e.g. dairy or gluten), ongoing or former drug abuse, high intake of alcohol (defined as a weekly intake of &gt;7 units for women and &gt; 14 units for men), pregnancy or ongoing planning of pregnancy, vegetarianism or veganism, participation in other scientific studies during the study period, and blood donation during - or in the month leading up to - the study period</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="255115">
        <text>- Transplant biopsy showing interstitial fibrosis and tubular atrophy of grade II or greater, with some evidence of lymphocytic infiltration (biopsy is NOT a study procedure, it would be performed as part of the patient's SOC)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="261026">
        <text>- Documented history of nonvalvular atrial fibrillation</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="261876">
        <text>- History of</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="265750">
        <text>- Subject has voluntarily agreed to participate by giving written informed consent. If subject has agreed to a newly obtained biopsy of tumor (that can be biopsied based on Investigator's assessment). Tissue obtained for the biopsy must not be previously irradiated. No systemic antineoplastic therapy may be received by the subject between the time of the biopsy and the first administration of KN035.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="271698">
        <text>- Not at risk for general anesthesia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="271973">
        <text>- Willing to discontinue medications with bowel altering side effects</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="277365">
        <text>Men undergoing a prostate cancer biopsy at Ann Arbor, Durham, San Francisco, or Pittsburgh VAs. Additional inclusion criteria includes ability to speak English, provide informed consent, and have a PSA &lt; 20.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="280364">
        <text>- Prior adjuvant or neoadjuvant taxane chemotherapy within 12 months prior to Day 1</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="287480">
        <text>- Active substance abuse</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="292384">
        <text>- Any contraindication to magnetic resonance scanning, including claustrophobia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="301955">
        <text>- Patients with concurrent serious infections.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="305511">
        <text>- Participant is receiving physical therapy, heat therapy, ultrasound, spinal manipulation, cognitive-behavioral therapy, biofeedback or anticonvulsants for his/her LBP.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="310445">
        <text>10. Must have a normal or clinically acceptable Physical examination (PE).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="323477">
        <text>6. Other severe diseases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="327977">
        <text>- History of risk factors for ventricular tachycardia or Torsades de pointes or history of fainting, unexplained loss of consciousness, or convulsions</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="329275">
        <text>- Having received a second dose of measles vaccine</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="335997">
        <text>4. Permanently immobile patient (wheelchair user or bed-ridden patient)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="336256">
        <text>- Documented bilateral oophorectomy;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="338446">
        <text>- Able to provide written informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="347880">
        <text>- Known congenital viral infection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="355897">
        <text>6. The presence of uncontrolled hypertension, uncontrolled diabetes, clinically significant cardiovascular disease, asthma or reduced pulmonary capacity, or a history of seizure or other neurologic disorder;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="358019">
        <text>- For all participants:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="360186">
        <text>- Participation in other biomedical research in the last one month or planned during the study</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="365907">
        <text>- A positive test for drugs of abuse at the screening visit</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="366627">
        <text>- Paresthesia or numbness of the small finger and/or ring finger</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="375102">
        <text>- Age ≥18 years</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="375170">
        <text>- ≥19 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="379096">
        <text>- Subjects with diagnosed malignancy, psychiatric disorders, or thyroid disorders (evaluated by medical history, physical examination, clinical symptoms, and assessment of thyroid stimulating hormone at screening)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="386911">
        <text>- No evidence of current or past schizophrenia, bipolar disorder, or organic mental disorder</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="390572">
        <text>- Prior chemotherapy other than hydroxyurea.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="391106">
        <text>2. Pleural/pericardial effusion or ascites estimated to be &gt;1L.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="394796">
        <text>- Previous surgical procedures for weight loss;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="396255">
        <text>6. Patient is, in the opinion of the investigator, willing and able to comply with the study medication regimen and all other study requirements.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="400794">
        <text>13. End stage renal disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="402647">
        <text>3. Patients must have a primary or metastatic lesion measurable in at least one dimension by RECIST criteria within 4 weeks prior to entry of study 4. More than 4 weeks must have elapsed from the time of major surgery or completion of the last dose of chemotherapy, radiation therapy, investigational therapy and patients must adequately recover from these effects.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="403386">
        <text>- Patients must not have received any prior systemic chemotherapy, thoracic radiotherapy or surgical resection for treatment of NSCLC</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="405918">
        <text>- Meets criteria for metabolic syndrome or insulin resistance</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="410971">
        <text>- Patients must be presenting in first, second or third relapse. Relapse is defined as progression following anti-cancer therapy other than surgery, including non-surgical therapies that are considered standard treatment for high-grade glioma if administered to patients with prior low-grade glioma. Prior therapy must have included external beam radiotherapy.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="413960">
        <text>- History of liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis B or C</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="414001">
        <text>- Nonstable doses of one or more of the following medications within 28 days before entry into the study: Hydroxychloroquine, Mycophenolate mofetil, Methotrexate, Azathioprine</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="414276">
        <text>- Current or past psychiatric (definitive Axis I) disorder</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="421440">
        <text>- Having experienced a medical event, which may confound study outcomes [e.g. heart attack, stroke, cancer (metastatic or newly diagnosed within last 5 years, except for non-melanoma skin cancer and breast), lupus, rheumatoid arthritis, chronic inflammatory disease]</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="423895">
        <text>- symptomatic bipolar disorder</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="428195">
        <text>INCLUSION CRITERIA OF PATIENT:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="436441">
        <text>5. No contraindication to assessment protocol and training</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="436635">
        <text>2. Seeking outpatient physical therapy for a unilateral TKR</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="438062">
        <text>- Ability to understand and willing to sign a written informed consent document</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="444954">
        <text>7. Female subjects of childbearing potential must use maximally effective birth control during the period of therapy, must be willing to use contraception for the duration of the study (up to 168 days post the IV infusion of Abatacept). They also must have a negative pregnancy test upon entry into the study. Otherwise, female subjects must be postmenopausal (no menstrual period for a minimum of 12 months) or surgically sterile.</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="449343">
        <text>- active airway disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="450889">
        <text>- Prior exposure to taxane in the adjuvant, neoadjuvant or metastatic setting</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="454211">
        <text>- Serum total bilirubin level ≤ 3.0 mg/dl in the absence of biliary obstruction (In the event of biliary obstruction, patients allocated to the CRT group must undergo interventional endoscopy or percutaneous drainage for biliary decompression. Post-interventionally, bilirubin levels should be ≤ 3.0 mg/dl before patients are subjected to CRT. In control patients undergoing upfront surgery, serum total bilirubin levels ≤ 10.0 mg/dl are tolerated, unless clinical and laboratory signs of severe cholangitis take place. Patients with serum total bilirubin level &gt; 10.0 mg/dl undergo preoperative biliary decompression, preferentially by interventional endoscopy)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="478689">
        <text>- Body weight less than 50 kg.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="481502">
        <text>- Skin intact on bilateral lower extremities</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="482860">
        <text>- Excessive physical activities (within one week prior to first administration of the trial drug of the trial drug or during the trial)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="483120">
        <text>4. Patient must have normal hepatic and renal function defined as: 1) AST (SGOT)/ALT (SGPT) &lt;/=3 x institutional upper limit of normal and 2) serum creatinine &lt;/= 2x institutional upper limit of normal.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="483414">
        <text>- Each subject will have his medical history taken and will receive a complete medical examination (incl. blood pressure and pulse rate measurements) as well as a 12-lead Electrocardiogram (ECG) within 14 days before the first administration of the test substance</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="489472">
        <text>- Injectable</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="491104">
        <text>Males and females over the age of 18 without IPF.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="501055">
        <text>- Patient has a relative or caregiver who is willing and capable to support the clinical trial; his/her written informed consent is optional</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="501214">
        <text>- seeking or receiving services at the Canandaigua VA Medical Center (VAMC) or Rochester Outpatient Clinic;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="505407">
        <text>- Are currently receiving or have previously received endocrine therapy for locoregionally recurrent or metastatic breast cancer</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="511984">
        <text>1. Have any history or evidence suggestive of seizure disorder or brain injury</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="513878">
        <text>- &gt;= Common Terminology Criteria for Adverse Events (CTCAE) grade 3 anxiety</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="518215">
        <text>- inability to communicate verbally in the appropriate language in a group setting (either due to lack of language skills, hearing impairment, or other disability)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="519075">
        <text>- Age 18 or older at the time of consent</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="526969">
        <text>- Allergy to Nicardipine or known hypersensitivity to Nicardipine.</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="529877">
        <text>- No history of variceal bleeding.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="533256">
        <text>- History/physical examination within 2 weeks prior to registration</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="537908">
        <text>- Known HIV carrier</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="541397">
        <text>- Subject received oral concomitant analgesics (including opioids) for HS-related pain within 14 days prior to Baseline visit.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="541841">
        <text>- Subjects where the carer's English is not fluent and translational services are not available</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="543353">
        <text>- All patients will be questioned about prior exposure to antibody therapy (including OKT3, rituximab, trastuzumab, and gemtuzumab) without affect to eligibility. Patients with prior exposure will have a blood sample collected for human antimouse antibody (HAMA). For patients with no prior antibody therapy exposure, no further action will be taken.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="547005">
        <text>5. Male patient agrees to use an acceptable method for contraception (i.e., condom or abstinence) during study drug therapy (including dose interruption) and for 4 weeks after discontinuation of bortezomib therapy.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="549610">
        <text>3. Any serious chronic or progressive disease according to judgment of the investigator (e.g. neoplasm, insulin dependent diabetes, cardiac, renal or hepatic disease);</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="553791">
        <text>8. For Part 3, subject has ovarian cancer that was previously treated with platinum based chemotherapy resulting in progression free survival for &lt; 6 months from the completion of treatment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="556353">
        <text>- Previous thromboembolism/arrhythmias</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="560035">
        <text>- A positive test result for urine toxicology.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="580062">
        <text>- A WHO performance status of 0 or 1. Radiotherapy alone is allowed if given pre or post protocol treatment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="582853">
        <text>- Contraindication to any of the components of the polypill (e.g. known intolerance to aspirin, statins, or ACE inhibitors; pregnancy or likely to become pregnant or breastfeeding women during the treatment period). Such contraindications are fully listed in the Investigator Brochures.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="586230">
        <text>- Body Mass Index (BMI) maximum 40 kg/m^2</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="588218">
        <text>- Inability to provide informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="593027">
        <text>- Vital signs (after 3 minutes resting measured in the supine position) should be within normal ranges as deemed by the Investigator.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="595059">
        <text>- Age 18 or above, or of legal age to give informed consent specific to national law</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="602716">
        <text>- Fertile women of ≥ 16 years of age must use at least one of the following contraceptives for at least one month prior to initiation of trial participance: Oral contraceptive, contraceptive diaphragm, intrauterine contraceptive device (coil), tube ligation. For girls between 12 and 15 years of age a written confirmation of sexual abstinence, given by a person having the care and custody of the child, is sufficient.</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="617383">
        <text>2. pregnant or lactating women, and pregnancy may not take effective contraceptive measures;</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="623783">
        <text>- Hypersensibility to ursolic acid o calcined magnesia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="625306">
        <text>- Subjects with a critical illness or who are immunocompromised</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="632623">
        <text>- has concurrent intracranial tumors, intracranial aneurysm or arteriovenous malformation.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="632744">
        <text>1. Multiple Myeloma of IgM subtype.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="636426">
        <text>- Medically appropriate candidate for radical cystectomy, as per NYU Attending Urologic Oncologist</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="636777">
        <text>- Clinical laboratory test values are outside the accepted normal range</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="639423">
        <text>1. Estimated glomerular filtration rate 20-45 mls/min/1.73m2; or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="641347">
        <text>- Subject treated by radiotherapy for a skin hemangioma in childhood at Gustave Roussy between 1941 and 1973 and who have received less than 1 Gy of radiation doses in the brain</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="641918">
        <text>3. Subjects must be treated with a stable opioid regimen at a total daily dose on average of ≥ 30 mg equivalents of oral morphine sulfate</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="644695">
        <text>- Inability to take or absorb oral medicine</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="648129">
        <text>- the Inclusion of patients with prior or concurrent malignancy (≤ 5 years prior to enrolment in study) must be discussed</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="651677">
        <text>- lesions in coronary artery bypass grafts</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="652678">
        <text>- Any other condition or circumstance that the investigator considers should exclude the patients or that could interfere with the interpretation of the study results</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="652952">
        <text>- Participants who are unable to understand the study protocol or unable to give informed consent, and have no legal representative.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="653769">
        <text>- dialysis or continuous venovenous hemofiltration before recruitment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="660575">
        <text>- Women with previous LSIL history may be included.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="661244">
        <text>- Tricuspidal- and or artificial aortic valve</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="661835">
        <text>- Breast feeding (current)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="662494">
        <text>9. Patients who have a recent history of drug substance or alcohol abuse.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="664118">
        <text>- active psychosis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="665983">
        <text>Adequate bone marrow function, defined as follows:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="667235">
        <text>- No signed informed consent by both parents</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="680558">
        <text>2. Chronic medically refractory atrial tachyarrhythmias</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="681913">
        <text>- Patients reporting prior use of "Ecstasy" more than 5 times or at any time within the previous 6 months.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="683893">
        <text>- Typical angina pectoris symptoms at rest or during exercise</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="686723">
        <text>- Medical or psychiatric conditions which, in the opinion of the Investigator, make participation in an investigational trial of this nature a poor risk.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="687258">
        <text>- Pulmonary lymphangitic involvement that results in pulmonary dysfunction requiring active treatment, including the use of oxygen</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="687945">
        <text>- use of any alpha-adrenoreceptor agonists (e.g. pseudoephedrine, phenylephrine, ephedrine) or anticholinergics (e.g. oxybutynin, propantheline) or cholinergics (e.g. bethanecol chloride) within 48 hours prior to all uroflowmetry assessments.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="695885">
        <text>- Subject has any condition which makes the subject unsuitable for study participation (e.g. ophthalmic conditions such as advanced cataracts).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="704149">
        <text>- Patients who are prisoners</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="704173">
        <text>- Active infection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="705358">
        <text>- Patient participating to a biomedical research with drug</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="713518">
        <text>- Women must not be breastfeeding. d) WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment with study drugs saxagliptin and dapagliflozin plus 5 half lives of study drug dapagliflozin (the longer half life between the 2 drugs; 3 days) for a total of 3 days following treatment completion.</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="713786">
        <text>- Patient has evidence of active viral illness (e.g., tuberculosis, ocular herpes simplex, chickenpox or measles).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="714028">
        <text>- sufficiently fluent in English to ensure valid understanding and completion of the tasks.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="714103">
        <text>- body mass index (BMI) between 18 kg/m2 and 42 kg/m2, inclusive, based upon the height and weight at screening</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="726449">
        <text>History of cryptorchidism.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="726612">
        <text>- Current abuse of alcohol or drug addiction that may interfere with the subject's ability to comply with trial procedures</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="736058">
        <text>17. Subjects who started hormonal treatment (for medical conditions or birth control) within less than 3 months.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="736824">
        <text>Facilitators</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="738261">
        <text>- Prisoners or subjects who are compulsorily detained (involuntarily incarcerated) for treatment of either a psychiatric or physical (i.e. infections disease) illness must not be enrolled into this study;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="738669">
        <text>- At least 2 consecutive previous treatment cycles of BoNT-A for current diagnosis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="740073">
        <text>- Adequate haematological laboratory parameters:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="741944">
        <text>- Recent (within 6 months) cerebrovascular accident (CVA) or transient ischemic attack (TIA)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="743254">
        <text>4. 4. All patients must have thorough tumor staging and meet at least one of the following criteria: a. Either lymph node biopsy or lymph node dissection demonstrating lymph node metastasis by prostate cancer; b. Non-bulky (&lt; 5 cm) regional pelvic or distant lymphadenopathy visualized on CT/MRI scan. Lymph node biopsy is required if &lt; 2.0 cm or in atypical distribution. c. Primary tumor Gleason score &gt;/= 8 and serum PSA concentration &gt;/=25 ng/mL, indicating high risk of occult lymph node metastases. d. Primary clinical tumor stage of T3 and Gleason score &gt;/= 7, indicating high risk of occult lymph node metastases. e. Primary tumor stage T4, indicating high risk of occult lymph node metastases. Patients in any of these groups and less than 3 sites of non-predominantly lytic bone metastasis will be still considered eligible for the trial. The 2010 AJCC staging system will be followed.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="750906">
        <text>- Subject has a history of pressure ulcer / DTI in same location.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="751401">
        <text>- Type 1 diabetes or Type 2 diabetes with medication known to induce hypoglycemia (f.e. Sulfonylurea derivatives</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="759414">
        <text>3. Donation or loss of 500 mL or more of blood within 8 weeks prior to the first dose of investigational drug.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="760191">
        <text>- Immunodepressed patients</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="760445">
        <text>- Administration of a depot antipsychotic injection within one dosing interval (for the depot) before randomization</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="761076">
        <text>- Subject is &gt;18 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="762457">
        <text>- The travellers not visiting areas with chloroquine resistant malaria</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="763916">
        <text>- ASA score of &gt; 4</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="766679">
        <text>- Calcium (albumin corrected) serum values below 7.0 mg/dL or above 10.0 mg/dL</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="769851">
        <text>- History of chronic pancreatitis or idiopathic acute pancreatitis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="771993">
        <text>- More than 14 grams of fiber per 1000 kcal per day</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="775149">
        <text>13. History of a hypersensitivity reaction to more than three drugs</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="780757">
        <text>- Hormonal contraception plus a barrier method. Hormonal contraception alone will not be considered adequate for inclusion into or participation in this study due to one of the study drugs being rifampicin.</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="780892">
        <text>4. Has the patient ever had facial radiotherapy or is the patient scheduled to facial radiotherapy?</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="780915">
        <text>5. drug abuse including alcoholism or addiction to cocaine, heroin or amphetamines</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="781374">
        <text>Other protocol-defined inclusion/exclusion criteria may apply</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="798604">
        <text>- Hearing loss</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="801882">
        <text>- History of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, congestive heart failure, hypertensive encephalopathy, stroke or TIA within the last 6 months.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="803338">
        <text>- Subjects must have a body mass index (BMI) between 18 and 30 kg/m2, with a bodyweight of &gt;50 kg</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="806564">
        <text>- Systolic BP ≥140 mmHg, or diastolic BP ≥90 mmHg on at least 2 occasions AND</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="808646">
        <text>- Age 18-70;</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="814401">
        <text>1. Pregnancy or lactation.</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="821260">
        <text>- Patient participating in another clinical study that investigates a drug or device</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="822417">
        <text>- Infants known to be at risk of anemia due to isoimmunization (mother has red blood cell antibodies</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="824941">
        <text>- Patients with pulmonary diseases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="828151">
        <text>- Serious cognitive or psychiatric problems (i.e. depression, alcohol dependency, or psychotic disorders).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="830104">
        <text>- Subjects with infected burn wounds</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="833945">
        <text>- Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 2 (Karnofsky &gt;= 60%)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="834897">
        <text>- Subject must have measurable disease and must be a candidate for intralesional therapy with at least one injectable cutaneous, subcutaneous, or nodal melanoma lesion (≥ 10 mm in longest diameter) or with multiple injectable lesions that in aggregate have a longest diameter of ≥ 10 mm.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="835315">
        <text>- Acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="836827">
        <text>- Any indication of compromised liver function that would otherwise contraindicate use of itraconazole</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="840316">
        <text>8. Active infection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="842896">
        <text>- Present to the emergency department with a migraine headache as defined by the modified Irma criteria. The modified Irma criteria are as follows: Headache episodes of 1-72 hours presenting with at least 3 of the following 6 criteria: moderate to severe episode of impaired daily activities; focal localization of headache; pulsatile description; nausea or vomiting or abdominal pain; photophobia or phonophobia or avoidance of light and noise; symptoms increasing with activity or resolving by rest.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="845175">
        <text>- Alpha-1 antitrypsin deficiency</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="847025">
        <text>1. presence of hepatic encephalopathy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="848544">
        <text>- Ability to understand the protocol and provide informed consent.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="858057">
        <text>- Have received previous treatment for ovarian cancer that included a platinum based chemotherapy regimen</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="858414">
        <text>4. Hemoglobin (Hb) values in 4 screening visits and the mean Hb must be between 9.0 and 12.0 g/dL (inclusive), and the difference between them must be ≤1.5 g/dL.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="859795">
        <text>- age ≥ 18 years,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="861395">
        <text>- Subject has a significant cardiovascular disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="863674">
        <text>- Clinically significant immune-related diseases or significant recent co-morbidities</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="874528">
        <text>6. Females of childbearing potential must have a negative pregnancy test result and must agree to use a medically acceptable method of contraception throughout the entire study period and for 30 days after the last dose of study drug.</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="877687">
        <text>- Patient must be able to give written informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="878787">
        <text>- Received experimental drug or device within 3 months prior to start of study</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="882716">
        <text>- Presence of adrenal gland diseases,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="885876">
        <text>- Youth scheduled to move from Oregon within the next year.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="888217">
        <text>- Patients with chronic disease between 18 -89 years old.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="889175">
        <text>- Viral load and CD4+ cell count history</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="889671">
        <text>10. fasting for 8-6 hours prior to surgery</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="893331">
        <text>- The total score of HAMD-17 is ≥18 and ≤30, AND item 1 ≥2 in both screening visit and baseline visit.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="901325">
        <text>- No cardiac disease that would preclude study participation</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="905533">
        <text>- Prior exposure of &gt; 360 mg/m2 doxorubicin or liposomal doxorubicin, &gt; 120 mg/m2 mitoxantrone, &gt; 90 mg/m2 idarubicin, or &gt; 720 mg/m2 epirubicin</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="910406">
        <text>- Female currently pregnant, planning a pregnancy or lactating</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="919904">
        <text>- Gastrointestinal (GI) tract disease resulting in an inability to take oral medication or a requirement for IV alimentation, prior surgical procedures affecting absorption, or active peptic ulcer disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="927124">
        <text>- Have received between one and 4 prior systemic treatments for metastatic triple negative breast cancer.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="928997">
        <text>1. Women who are pregnant (including positive pregnancy test at enrollment or prior to study drug administration) or breast-feeding.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="934672">
        <text>- traumatic cardiac arrest</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="939471">
        <text>- Does not cycle 2-3 times/week</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="940160">
        <text>- Any history of cardiovascular disease/active cardiovascular treatment(βblockers used for prevention of the variceal hemorrhage will be stopped 24h before the evaluation);</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="943833">
        <text>- Episode duration ≥ 3 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="946582">
        <text>- Platelet count ≥ 100 x 109/L</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="947044">
        <text>- Participant has a transplanted organ, excluding corneal transplant, performed &gt; 3 months prior to the first dose of trial medication</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="949362">
        <text>- Leukemia or MDS or PNH or Fanconi's Disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="952568">
        <text>- hypertension</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="956347">
        <text>- Adequate hematological function</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="957318">
        <text>- No more than 2 prior chemotherapy regimens</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="960846">
        <text>- ECOG performance status greater than 2</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="961545">
        <text>- Subjects who have a history of cancer to an affected limb that results in a surgical amputation maybe eligible.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="964891">
        <text>- Preoperative intra-aortic balloon pump (IABP)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="970448">
        <text>- with a negative pregnancy test</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="971870">
        <text>- cancer or other hematologic malignancy during treatment or in remission for less than 5 years.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="973029">
        <text>- DPP-4 inhibitors (sitagliptin, saxagliptin, alogliptin, linaglyptin)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="977135">
        <text>- Uncontrolled thyroid disease (TSH undetectable or &gt;10); testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="978491">
        <text>(4) ECOG scores 3-4 (5) combined with serious diseases of other organs.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="980573">
        <text>- Women not of childbearing potential due to surgical sterilization (hysterectomy or bilateral oophorectomy or tubal ligation) or menopause</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="984545">
        <text>- Patient has intolerable to dual anti-platelet therapy.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="994517">
        <text>Patients must be greater than or equal to 18 years of age.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="994845">
        <text>- Alcohol and/or any other drug abuse</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="995333">
        <text>Unable to provide informed consent.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="995967">
        <text>Subjects who have had confirmation of a Pro250Arg mutation in FGFR3 by a CLIA-certified laboratory. Our research team must receive a photocopy of the positive test result in order to enroll a patient in the study. All races and genders are known to be at risk for Muenke syndrome. Nationality or place of origin is not a specific barrier to participation.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="999333">
        <text>- Received no previous chemotherapy for B-CLL.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1000841">
        <text>- Patients with the following organ dysfunction symptomatic coronary artery disease or ejection fraction &lt; 35% or other cardiac failure requiring therapy; ejection fraction is required if the patient is &gt; 50 years of age, or history of cardiac disease or anthracycline exposure</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1002406">
        <text>- Patient is known to be hepatitis B surface antigen-positive or has known active hepatitis C infection.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1002946">
        <text>- HBeAg positive and anti-HBe negative OR HBeAg negative (pre-core mutant) and anti-HBe positive with positive HBsAg for the previous 6 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1017259">
        <text>- Subject has active systemic infection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1020543">
        <text>8. History of clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic diseases, in the opinion of the Principal Investigator, would jeopardize the safety of the subject or impact the validity of the study results.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1025011">
        <text>3. known multi-fetal pregnancy at enrolment</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1026206">
        <text>- less than 6 months of follow-up after surgery</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1028097">
        <text>- Respiratory symptoms/signs (patients pulse oximetry &lt; 92% or oxygen saturation &lt; 2% below their baseline, tachypnea, cough, and increased work of breathing)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1033088">
        <text>- Pregnant state</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1041986">
        <text>May not be receiving other concurrent chemotherapy or radiation therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1043429">
        <text>- Disease and/or medical conditions accompanied by hypercalcaemia and/or hypercalciuria</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1045443">
        <text>- Participants for whom no standard therapy exists</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1049008">
        <text>- Body Mass Index (BMI) equal to 40 kg/m^2 or below</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1050535">
        <text>- Subjects requiring control medication against asthma (bronchodilator nebulised drugs or local or systemic corticosteroids)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1055084">
        <text>- Diagnosis of active plaque psoriasis or nail changes consistent with psoriasis or documented history of plaque psoriasis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1058940">
        <text>- History of hypersensitivity to any of the study drugs or to drugs with similar chemical class, or to any of the excipients</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1059889">
        <text>- Age 24-65</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1060026">
        <text>7. Use of anticoagulant medications.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1063916">
        <text>- Target Disease Exceptions</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1064500">
        <text>- Pain originating from ear</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1065714">
        <text>- with contrast medium injection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1072682">
        <text>8. Patient is capable of meeting requirements and be present at the follow-up clinic visits at 30 days.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1076396">
        <text>-No history of psychiatric disorder or neurological illness</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1083193">
        <text>- Pregnant or lactating women.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1083275">
        <text>- Discontinuation of growth factors (e.g., G- CSF) at least 2 weeks prior to study entry</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1085532">
        <text>- is capable of giving written informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1086605">
        <text>- No reported participation in another nutritional or biomedical trial 3 months before screening;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1089852">
        <text>- Pregnancy/lactation or male subjects whose female partners are pregnant</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1093240">
        <text>- Transfusions are permitted to meet both the platelet and hemoglobin criteria; patients must not be known to be refractory to red blood cell or platelet transfusions</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1100215">
        <text>- Physically and mentally healthy subjects</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1100244">
        <text>- Chronic back pain</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1113941">
        <text>10. ECOG Performance Status (PS) of 0, 1 or 2.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1115412">
        <text>- presence of COPD with chronic respiratory global insufficiency</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1117236">
        <text>- Left Ventricular Ejection Fraction (LVEF) &lt; 30%;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1121287">
        <text>3. Presence of illicit drug and/or alcohol dependence.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1129175">
        <text>2. Worse than moderate ascites (beyond over pelvic cavity)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1134708">
        <text>- In good health as determined by medical history and physical examination (including blood pressure and heart rate).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1135028">
        <text>- Patients with pre-planned elective surgery that is likely to change or impact on the control of PD symptoms, or involve hospitalisation.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1136649">
        <text>- Older than 18 years and younger than 60 years; without regard to CD4 count;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1137688">
        <text>7. Patients with known significant allergy to Vancomycin</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1138865">
        <text>- Patients blood glucose &gt; 11.1 mmol/L (200 mg/dL) measured by glucometer immediately prior to scan.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1139199">
        <text>- Enrollment in another clinical trial</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1140082">
        <text>- non-smoker</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1146440">
        <text>- Evidence of hepatic decompensation (history or current evidence of ascites, bleeding varices or hepatic encephalopathy).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1150499">
        <text>2. Patients must have one of the following: elevated b2-microglobulin levels (defined as 2 times compared to normal), carry a JAK2 mutation, or presence of phosphorylated p65 NF-kB component in at least 5% of bone marrow cells.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1154191">
        <text>5. Active infection requiring systemic antibiotic therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1154241">
        <text>1. Age 18-years or older</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1159280">
        <text>4. Patients with increased risk of regurgitation and aspiration (non-fasting patients, gastroesophageal reflux disease etc.)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1161330">
        <text>Normal renal function at screening, as defined by</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1161352">
        <text>Current, clinically significant malabsorption</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1163734">
        <text>- Past medical history of: liver dysfunction (ie: cirrhosis), chronic alcohol abuse, gastrointestinal bleed or recent gastrointestinal bleed (within past 5 days), renal dysfunction or disease, seizures (or currently actively receiving treatment for seizures), inflammatory bowel disease (or currently actively receiving treatment for inflammatory bowel disease), hepatitis (or currently actively receiving treatment for hepatitis).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1164749">
        <text>- Unable to consume test-dose of RUTF in clinic</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1165203">
        <text>- history of mania or hypomania within the past two years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1179435">
        <text>- Interruption of thromboprophylaxis (e.g., heparin, LMWH, warfarin, aspirin, dabigatran, clopidogrel) would pose an unacceptable health risk (e.g., patient with an abnormal bleeding time), as determined by physician</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1183688">
        <text>- Does the patient have an absolute neutrophil count of ≥ 1500/mm3, and platelets ≥ 100,000/mm3</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1186232">
        <text>5. Failure to response to voice training or other non-surgical treatments</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1186311">
        <text>- Male and female subjects who are receiving skin testing or allergen immunotherapy from one allergy practice.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1188465">
        <text>- medical instability</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1203955">
        <text>- ankle-brachial index (ABI) ( 50-90% and/or toe pressure 50-70% and where ankle pressure &gt; 60 mmHg or toe pressure &gt; 40 mmHg</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1204686">
        <text>3. PHQ-8 score of 15 or greater on the baseline interview</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1204987">
        <text>1. Bone marrow reserve consistent with: absolute neutrophil count ≥ 1.5 x 109/L, platelet count ≥ 100 x 109/L, and hemoglobin ≥ 9 g/dL (without transfusion) within 1 week preceding the administration of the study drugs;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1211392">
        <text>- Diagnosis of end-stage renal disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1213530">
        <text>10. Inability to comply with treatment and follow-up schedule</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1213659">
        <text>- Treatment with any enzyme replacement therapy for Fabry disease within 3 months before study entry;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1213845">
        <text>- Willing to complete evaluation forms</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1216841">
        <text>3. Able to take in oral fluids.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1222652">
        <text>- Visual impairments such as uncorrected vision or color blindness</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1223117">
        <text>- The patient is under judicial protection, or is an adult under guardianship</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1225305">
        <text>- Female who participated in a Phase 1, 2 or 3 clinical study with Ad26.ZEBOV and/or MVA-BN-Filo and became pregnant with estimated conception within 28 days after vaccination with MVA-BN-Filo or within 3 months after vaccination with Ad26.ZEBOV (Cohort 2)</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1225312">
        <text>- Patients must receive their primary oncology care in the participating hospital</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1225451">
        <text>- Patients with active or suspected ocular or periocular infections</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1228373">
        <text>- No genomic alteration of TP53</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1228485">
        <text>3. Serum creatinine ≤ 1.5 x upper limit of normal</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1230090">
        <text>- Male subject and their female spouse/partners who are of childbearing potential must be using highly effective contraception consisting of two forms of birth control (one of which must be a barrier method) starting at screening and continuing throughout the study period and for 90 days after the final study drug administration.</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1235371">
        <text>- Donating blood 2 months within or during study period</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1236296">
        <text>- Smokers or use of any tobacco products in past 6 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1236973">
        <text>- The use of inhaled corticosteroids and mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1240650">
        <text>15. Prisoners or patients in custody</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1241025">
        <text>- Hemoglobin ≥ 9.0 g/dL. Patients may be transfused to meet this criterion.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1245993">
        <text>- Patients with medical conditions and/or taking concomitant medications that would have put them at risk, interfered with the study evaluations, or made them unable to complete the requirements of the study;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1255200">
        <text>3. Right-handedness assessed by the Edinburg handedness inventory</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1264652">
        <text>- normal renal function (creatininemia &lt;1.2 mg/dl)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1265510">
        <text>4. Subject requires long-term use of vitamin K antagonists</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1268266">
        <text>- Serious hearing or visual impairment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1272003">
        <text>- Participants who are able to give written informed consent and willing to comply with all study-related procedures.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1279105">
        <text>- Gestational age ≥ 37 weeks;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1287785">
        <text>- Had at least one prenatal visit during which pregnancy was confirmed.</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1287819">
        <text>- Plan to travel outside of North America in the time between vaccination and 21 days following vaccination</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1290744">
        <text>- Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1293632">
        <text>- Other exclusion criteria apply according to the US Product Information</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1293795">
        <text>- Presence of any hypersensitivity to drugs similar to azelastine and to either sorbitol or sucralose (Splenda® brand sweetener)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1296688">
        <text>Patients must have histologically or cytologically confirmed indolent Non-Hodgkin's Lymphoma; included in this category are newly diagnosed or relapsed/refractory follicular center lymphomas grade I, II, III, relapsed/refractory marginal zone B-cell lymphoma (nodal and extranodal), relapsed/refractory mantle cell lymphoma</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1296744">
        <text>6. Infection with human immunodeficiency virus (HIV) and/or chronic/active infection with hepatitis B virus or hepatitis C virus</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1299134">
        <text>obese family history of diabetes</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1301792">
        <text>9. Willing to provide proof of identity by photographic ID at screen and any subsequent visit</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1301994">
        <text>5. History of anaphylactic reaction attributed to any contrast agent or drugs containing polyethylene glycol (PEG).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1307133">
        <text>2. Any uncontrolled infection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1307397">
        <text>- Patients must be suitable for and willing to undergo a radical prostatectomy at the completion of study therapy.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1308128">
        <text>- Spinal cord compression and/or brain metastases unless asymptomatic or treated &amp;amp; stable off steroids for at least 4 weeks</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1310229">
        <text>- Male or female subjects at least 18 to 75 years at the time of screening;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1312072">
        <text>2. Any person who replies "Yes" when asked "Do you smoke?".</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1319736">
        <text>3. Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the areas to be treated, including presence of malignant or pre‐malignant pigmented lesions</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1323003">
        <text>- Serum potassium : greater than 5.5 mmol/L</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1323360">
        <text>- Patient with acute hepatitis due to any cause or clinically significant chronic liver disease including but not limited to cirrhosis, ascites, encephalopathy, hypoalbuminemia, prolonged PT/PTT and/or esophageal varices.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1324182">
        <text>1. patients aged under 18 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1327793">
        <text>- DNAR (Do Not Attempt Resuscitation) order in place</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1328169">
        <text>6. For patients with hormone receptor-positive disease: disease progression or recurrence in any setting on prior hormonal therapy, given with or without HER2 directed therapy.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1334845">
        <text>- Patients with congenital spinal deformity</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1337227">
        <text>- Refuse to participate in the Protocol</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1338613">
        <text>12. A positive β-hCG test at enrollment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1338841">
        <text>- Undergoing an autologous or reduced intensity conditioning (RIC) allogeneic HSCT</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1340730">
        <text>- Post-menopausal or surgically sterile, or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1341311">
        <text>- Oral maintenance treatment with azathioprine or 6-mercaptopurine (taken for at least 6 months at stable dose and continued at the same dose throughout the study) is permitted.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1342789">
        <text>- Body mass index &gt; 35 mg/kg</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1344982">
        <text>- HBeAg positive or HBeAg negative</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1345098">
        <text>3. Migraine with aura; at least 2 attacks with 3 of following:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1347445">
        <text>- Nephrosis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1347572">
        <text>- acute or chronic severe renal insufficiency (glomerular filtration rate &lt;30 mL/min/1.73m2), as calculated by the MDRD (Modification of diet in Renal Disease) equation, or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1356370">
        <text>- other exclusion criteria will be: tobacco use, habitual alcohol use of more than 1 drink per day, excessive caffeine intake of more than 300 mg per day</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1358350">
        <text>- The patient has a resectable tumor or cyst arising from the pancreatic exocrine gland (pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasm of the pancreas, or mucinous cystic neoplasm of the pancreas) and is undergoing surgical resection of the neoplasm.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1362711">
        <text>- Schizophrenia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1365947">
        <text>1. Patients with asthma who are primarily cared for by a Respirologist/Pulmonologist;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1374903">
        <text>- Since each subject is receiving a gadolinium based contrast agent intravenously:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1377433">
        <text>4. History of life-threatening respiratory distress that requires admission to an intensive care unit for treatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1379806">
        <text>- Prior history of hyperglycemic crises.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1387049">
        <text>7. Creatinine clearance (CrCl) &gt; 30 mL/min, measured or calculated according to Cockcroft and Gault's formula.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1391505">
        <text>2. Ability to comply with the protocol.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1392258">
        <text>- diabetes, other significant medical problem or intercurrent acute illness that in the Nurse Practitioner's and/or Principal Investigator, would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objective.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1396518">
        <text>- Participant is hepatitis B surface antigen (HBsAg) positive or hepatitis C virus (HCV) antibody positive with HCV RNA positive, or has another clinically active liver disease at screening</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1399550">
        <text>- Peritoneal and/or pleural fluid drainage within 28 days prior to screening</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1401482">
        <text>- Known psychiatric disorders</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1404685">
        <text>6. Continuing or restarting their first-line antiretroviral therapy OR planned to be switched to a second line ART regimen with at least two active agents (per clinician judgment or genotype evidence) at enrollment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1406032">
        <text>- Written informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1406247">
        <text>- Mothers of children aged 0-12 mo. or pregnant at time of enrollment</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1413350">
        <text>EXCLUSION CRITERIA:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1413789">
        <text>- 50% extrasystole</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1416384">
        <text>- Women seen at the Gynecologic Oncology Clinic at the Lyndon Baines Johnson General Hospital. The women must be able to read and write either English or Spanish.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1417170">
        <text>- Inability to adhere to blood age randomization due to limitations of the blood bank inventory</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1419234">
        <text>PATIENT CHARACTERISTICS:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1419393">
        <text>- Unable to comply with the study protocol.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1420312">
        <text>- Willingness to provide written informed consent to participate in the study.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1420450">
        <text>3. Other (non-diabetic) retinal vasculopathy in the study eye</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1425619">
        <text>13. Patients must not have received: cytochrome P450 3A4 (CYP3A4) inhibitors within seven (7) days prior to registration on protocol and for the duration of the study. However, amiodarone, another CYP3A4 inhibitor, should have been discontinued 6 months prior to registration and for the duration of the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1433093">
        <text>11. Core biopsy or other minor surgical procedure, excluding placement of a vascular access device, within 7 days prior to study enrollment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1441709">
        <text>- Absence of contraindication to iodinated contrast medium injection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1443380">
        <text>- age 18-65 years old;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1445485">
        <text>- Systemic diseases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1449875">
        <text>- Patients with acceptable oral hygiene level,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1450112">
        <text>- Pregnant</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1451530">
        <text>- Use of drugs: Weight lowering agents, glucocorticoids, Oral contraceptive pills.</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1452571">
        <text>9. CT measurable disease with at least 1 lesion having short axis ≥ 1.5cm or splenomegaly ≥ 14cm in cranio-caudal length attributable to relapsed lymphoma</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1460390">
        <text>- MDS:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1461924">
        <text>- Patient must not have received immune suppressants: corticosteroids (for other than allergic reactions and anaphylaxis), cyclosporine or tacrolimus within 7 days of enrollment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1462240">
        <text>- Severe lung disease: FEV1/FVC &lt;0.5 and total lung capacity &lt; 70% of the normal value</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1463072">
        <text>- Significant diminished mental capacity that is unable to understand the protocol, surveys and questionnaires; unable to read/write English or Spanish.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1463579">
        <text>28. Previous bone marrow transplant.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1464931">
        <text>8. Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1472957">
        <text>8. Subject has facial hair that could interfere with the study assessments in the opinion of the investigator.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1476708">
        <text>15. Pregnant or lactating females.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1490355">
        <text>3. Significant heart failure (NYHA class III and IV)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1493631">
        <text>14. Inability of subject to understand and sign the ICF;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1493785">
        <text>- Subject engaged in unprotected intercourse with more than 2 persons in the previous 6 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1496000">
        <text>- On therapy with a drug that would affect collagen synthesis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1509456">
        <text>- Concurrent participation in any another study for people with dementia/carers</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1514135">
        <text>6. Evidence or symptoms consistent with autonomic dysfunction (e.g., orthostatic hypotension and/or autonomic symptoms) as defined in the protocol</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1515923">
        <text>7. Current participation in any clinical trial or any other non-interventional study of a drug or device</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1520037">
        <text>- Rheumatoid arthritis, evidence/suspicion of infectious/septic arthritis, or other acute inflammatory arthritis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1528758">
        <text>- Sexually active individuals capable of becoming pregnant or causing a pregnancy who are unable or unwilling to use appropriate contraceptives.</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1529612">
        <text>- Type 2 diabetes</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1537603">
        <text>- Congenital long QT syndrome</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1539072">
        <text>- Patient under guardianship or under judicial protection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1539137">
        <text>1. Age 30-70 years old</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1539873">
        <text>- Evidence of clinically significant immunosuppression</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1540162">
        <text>- Patient discomfort</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1544239">
        <text>4. Relapse or failure of one first line prior platinum-based chemotherapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1552531">
        <text>2. Active GPA in the ENT domain within 1 month prior to screening, where the active disease is defined as a score of ≥2 on a GPA ENT disease activity score (7 items scored as 1= present 0= absent) performed by direct endoscopic visualization of the upper airway and audiometric evaluation by a single expert otolaryngologist. Items included in the GPA ENT disease activity score are:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1553028">
        <text>24. Patients with respiratory failure, or stomach disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1555791">
        <text>- Adult cancer patients (&gt;18)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1556213">
        <text>- Any laboratory abnormality or condition that, in the investigator's opinion, could adversely affect the safety of the individual or impair the assessment of study results</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1556868">
        <text>- Absence of CRT with class I indication criteria for biventricular pacing - Subjects on high dose steroids or immunosuppressant therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1560128">
        <text>- History of blood coagulation pathology</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1565558">
        <text>- Age 45 years or older (older control group)</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1566187">
        <text>- Any agent for hypoglycemia, such as diazoxide or octreotide</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1568482">
        <text>- 21 years of age or older</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1574939">
        <text>2. Chronic hepatitis B defined by the presence of HBsAg for at least 6 months prior to screening period.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1579264">
        <text>- No prior radiation therapy to the head and neck sites.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1580241">
        <text>- contraindication for pneumoperitoneum</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1583845">
        <text>- A participant must have a diagnosis of histologically confirmed osteosarcoma or Ewing sarcoma;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1587376">
        <text>- Ages 18-65, based on the usual ages of patients seen in the adult neurology services who are not likely to suffer from the exclusions (see below), plus:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1588318">
        <text>- Men and women, who are at least 18 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1594663">
        <text>1. Has an HCC diagnosis by histology (can not have a mixed tumor type such as HCC and cholangiocarcinoma) OR by the following non-invasive criteria observed either within 14 days prior to first TACE or in the past.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1595329">
        <text>- Healthy, non-smoking (within 40 days of screening), adult males and females between 18 and 55 years of age, inclusive</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1598594">
        <text>- The patient underwent coronary angiography and subsequent angioplasty with deployment of a bare metal stent within de novo stenotic lesion.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1602392">
        <text>- Current pregnancy or lactating or planning to get pregnant</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1608605">
        <text>- Adult patients, 18-65 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1610733">
        <text>- Patient is greater than 18 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1620636">
        <text>4. AST and ALT ≤ 1.5 x ULN (or ≤ 3 x ULN in the presence of liver metastases).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1627218">
        <text>- Children and adolescent subjects 2-21 years of age at the time of the procedure, inclusive</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1635533">
        <text>10. The patient will provide written informed consent.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1636740">
        <text>- Uveitis limited to only the anterior segment of the study eye.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1639287">
        <text>- fasting blood sugar &gt; 110 mg/dl</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1639530">
        <text>- diseases requiring anticoagulant treatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1641671">
        <text>- Suspected contraindication or hypersensitivity to study medications tafluprost or timolol (e.g. asthma, low pulse) or to wash-out medication brinzolamide</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1645569">
        <text>- Adequate liver function: bilirubin ≤ 1.5 x upper limit of normal (UNL) range, ALAT and/or ASAT ≤ 2.5 x UNL, Alkaline Phosphatase ≤5 x UNL</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1652785">
        <text>- Patients must have bi-dimensionally measurable disease with a least one lesion greater than or equal to 2 cm x 2 cm by CT scan</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1657626">
        <text>- Parent/s or guardian of subject unable to maintain diary card</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1661652">
        <text>- Chronic pancreatitis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1668490">
        <text>- Cardiac arrhythmia requiring medical therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1671861">
        <text>- Sterilization of male partner; or,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1672408">
        <text>- Prior adjuvant or neo-adjuvant chemotherapy/radiotherapy allowed</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1685202">
        <text>- Subject has an acute psychiatric disorder or is cognitively impaired.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1688146">
        <text>- Able to attend 3 clinical visits during the study period</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1690294">
        <text>- No diagnosis of gastroparesis.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1694914">
        <text>4. Triglycerides &gt; 400 mg/dl</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1695802">
        <text>- Participants with peripheral sensory neuropathies with impaired functional activities</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1706049">
        <text>17. History of an ongoing, chronic or recurrent infectious disease including recurrent respiratory and/or urinary tract infections or evidence of tuberculosis infection as defined by a positive QuantiFERON TB-Gold test at screening. Subjects with a positive or indeterminate QuantiFERON TB-Gold test may participate in the study if further full tuberculosis work up (according to local practice/guidelines) completed at least 12 weeks prior to first study drug administration establishes conclusively that the subject has no evidence of active tuberculosis. If presence of latent tuberculosis is established, then treatment must have been initiated and maintained according to local country guidelines for at least 4 weeks prior to screening.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1709201">
        <text>- Clinically important active infections or infestations, chronic, recurrent or latent infections or infestations</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1713074">
        <text>- Prior or current use of systemic anti-vascular endothelial growth factor (VEGF) inhibitors, cytokines or mechanistic target of rapamycin (mTOR) inhibitors (e.g. interferon, interleukin 2).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1716293">
        <text>- Currently receiving any other investigational agents or having participated in an investigational therapy trial within 30 days.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1719166">
        <text>- Other malignancy within the last 3 years (except for basal cell carcinoma or a non-invasive/in situ cervical cancer)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1720537">
        <text>- Relapsed acute lymphoblastic leukemia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1722000">
        <text>- Refusal by a patient to do the PCA (anterior chamber puncture)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1722204">
        <text>9. immunosuppressants or biphosphonates</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1727915">
        <text>Surgery:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1732294">
        <text>3. Investigational biologics (2 months)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1735915">
        <text>Excluded:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1736022">
        <text>- Allowed:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1738973">
        <text>Prior Medication:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1739291">
        <text>- Oral or parenteral magnesium and calcium supplementation.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1739704">
        <text>A MMSE score less than or equal to 20.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1749333">
        <text>Patients will not be eligible for this study if they:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1751113">
        <text>- Corneal, lens, or vitreous opacification which precludes examination of the fundi in patients with CMV retinitis.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1754560">
        <text>- AL721.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1757815">
        <text>5. Donation of &gt; 500 mL of blood in the past 8 weeks prior to study drug dosing or difficulty in donating blood.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1762945">
        <text>- Other severe acute or chronic medical or psychiatric condition, or laboratory abnormality that may increase the risk associated with study participation or study drug administration or may interfere with the interpretation of study results and in the judgment of the investigator would make the patient inappropriate for entry into this study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1763655">
        <text>- Histologically proven malignancy (confirmed by Vanderbilt pathologists), advanced non-hematologic malignancy that is not curable by standard surgery, radiation therapy, or chemotherapy. Patients with melanoma, especially those with accessible tumors will be sought for this trial, but this part of the trial will not be limited to only melanoma patients</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1763827">
        <text>- Has had a documented (medical report verification) hysterectomy or double oophorectomy or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1769202">
        <text>3. Patients who need urgent shunt replacement and therefore cannot wait for the SHUNTCHECK evaluation of shunt patency.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1770518">
        <text>- Any patient with active cancer or a history of cancer with less than 5 years disease-free survival time.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1777950">
        <text>2. Currently using ocular lubricating drops at least once per day for, at least, the past 3 months;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1781226">
        <text>- eGFR &gt; 75 ml/min/1.73 m² at inclusion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1781497">
        <text>- Female between, and including, 18 and 55 years of age at the time of enrolment;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1782977">
        <text>6. Diagnosis of, or receiving treatment for malignancy (excluding basalioma skin cancer) in the previous 5 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1784768">
        <text>- uncontrolled type 2 diabetes mellitus</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1792570">
        <text>- Fully recovered from prior surgical procedures and recovered to ≤ grade 1 from adverse events due to previous treatments</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1794905">
        <text>- Unstable medical condition;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1795674">
        <text>- ECOG performance status 0-2 (Karnofsky ≥60%, see Appendix A)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1795981">
        <text>- Pregnant or lactating women</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1798620">
        <text>- &gt;18yr</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1801802">
        <text>7. History of chronic narcotic use, defined as more than 5mg of oxycodone q4 hours</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1812944">
        <text>3. Subjects cannot have known heptic or peritoneal metastases detected by ultrasound (US), CT scan, or laparotomy/laparoscopy prior to treatment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1816297">
        <text>- Type 1 diabetes mellitus patients</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1816443">
        <text>5. Use of biologic response modifiers, such as G-CSF, within 3 week of study entry. [G-CSF and other hematopoietic growth factors may be used in the management of acute toxicity such as febrile neutropenia when clinically indicated or at the discretion of the investigator; however they may not be substituted for a required dose reduction.] [Patients taking chronic erythropoietin are permitted provided no dose adjustment is undertaken within 2 months prior to the study or during the study]</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1817041">
        <text>- For the RPFNA/adipose tissue substudy: bilateral breast cancer, bilateral mastectomy, unable or unwilling to stop aspirin or NSAIDs for 1 week before and after the procedure, allergy to anesthetics or local anesthetics.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1819920">
        <text>- Never smokers, i.e. no cigarettes last year, and maximal 5 pack years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1829177">
        <text>- Female or Male patients</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1831065">
        <text>- Has no symptoms of Dry Eye</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1834525">
        <text>- Treatment with prior donor lymphocyte infusion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1837754">
        <text>- Patients who are not capable of complying with the procedures established by the protocol and of signing the informed consent. In case of minors or incapacitated patients unable to release their informed consent to take part in the study, the consent must be released and signed also by the parents/guardian or by the legal representative. Minors or incapacitated patients must as well sign the informed consent to the best of their ability.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1849815">
        <text>1. Histological confirmation of non-small cell lung cancer</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1851216">
        <text>- Concurrent use of other extracorporeal therapies such as extracorporeal membrane oxygenation, plasmapheresis or intermittent hemodialysis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1852303">
        <text>- Late onset congenital adrenal hyperplasia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1861254">
        <text>2. Having with cognitive alterations (score of &lt; 24/30 at the Folstein test)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1868573">
        <text>- Between 50 to 74 years old</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1870531">
        <text>- Radiotherapy to bone lesions, systemic surgery, orthopedic surgery (all within the 4 week prior to treatment with EMD525797), clinically significant unhealed wound, or unrecovered bone fracture</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1870943">
        <text>- Lidocaine allergy,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1874038">
        <text>- qualifying C-peptide value in a mixed meal test at visit 1</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1877444">
        <text>- Patient requiring surgical management for the cancer of the esophagus or stomach.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1882334">
        <text>23. Subject is currently a heavy user of nicotine, ie, smoking more than 20 cigarettes (eg, 1 pack) per day or equivalent (eg, e-vapor cigarette, pipe, cigar, chewing tobacco, nicotine patch or nicotine gum).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1883213">
        <text>- Ocular disease other than glaucoma that may affect assessment of visual acuity and/or IOP (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy, proliferative diabetic retinopathy, clinically significant macular edema…)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1886218">
        <text>- Unstable blood sugar control defined as one or more episodes of severe hypoglycemia (defined as hypoglycemia that required the assistance of another person) within the last 30 days</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1890217">
        <text>- Women of child-bearing potential must have a negative pregnancy test, cannot be breastfeeding and must be willing to use contraception</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1892423">
        <text>- on insulin for more than 5 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1896712">
        <text>- Plasma NT-proBNP (&gt;250ng/L in SR and &gt;1,000ng/L in AF)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1899935">
        <text>- The subject must be ≥ 18 years of age on day of signing informed consent.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1912358">
        <text>- Participants must have relapsed disease despite standard therapy.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1914747">
        <text>- Renal dysfunction (Glomerular filtration rate (GFR) &lt;30 mL/min/1.73m2)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1915484">
        <text>- Intellectual Disability (IQ &lt; 70)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1920771">
        <text>- Pregnancy or planning pregnancy during the duration of the study</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1923096">
        <text>7. Axis 2 diagnosis, chronic substance abuse, suicidality or disruptive to group dynamic</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1923438">
        <text>① Medications that are potent inhibitors of CYP3A4, including cyclosporine, systemic itraconazole or ketoconazole, erythromycin or clarithromycin, nefazodone, verapamil and human immunodeficiency virus (HIV) protease inhibitors.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1923862">
        <text>- Age at the time of inclusion: 55 -79y,</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1930822">
        <text>4. Patients received symptomatic treatment for bone marrow toxicity within 7 days prior to enrollment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1932237">
        <text>- Only adults (&gt;18 years old) will be included in this study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1936817">
        <text>- A positive pre-study drug/alcohol screen.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1940094">
        <text>Subjects must meet all of the following criteria to be included in the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1940594">
        <text>- hemodynamically unstable</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1941313">
        <text>- profound sensory loss/absent touch sensation</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1951167">
        <text>- Clinically unstable patients (e.g. intensive care unit)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1952488">
        <text>- Presence of at least one measurable central nervous system (CNS) target lesion (At least 5 mm in size)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1956193">
        <text>- Intake of antibiotics within past 6 weeks prior to inclusion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1968408">
        <text>- Endometrioma and/or Endometriosis-stage III or IV</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1974148">
        <text>- Unable to follow post-operative exercise regimen or return for evaluations</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1980188">
        <text>- Patients must sign a study-specific informed consent form prior to study entry.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1981750">
        <text>- Subjects with arterial or venous thrombotic or embolic events such as cerebrovascular accident (including transient ischemic attacks), deep vein thrombosis, or pulmonary embolism within the 6 months before start of study medication</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1982227">
        <text>- Systemic infections.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1991241">
        <text>- Ocular surgery in the previous 6 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1992187">
        <text>- Preeclampsia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1992873">
        <text>- Concurrent treatment with non-permitted drugs and other interventions</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1996428">
        <text>- Evidence of biochemical failure</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1996677">
        <text>- Acute confusional state.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1998146">
        <text>- age&gt;18 years of age;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="1998876">
        <text>- Currently with lice or open wounds on scalp.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1999423">
        <text>- female members of the couple may report that they have engaged in low level aggression during the past six months in their current relationship on the Revised Conflict Tactics Scale (CTS2; Straus et al., 1996)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="1999566">
        <text>- Histologically confirmed aggressive B cell non-Hodgkin lymphoma (NHL) including the following types defined by World Health Organization (WHO) 2008:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2013626">
        <text>- Lobectomy patients.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2020740">
        <text>- Telephone contact available</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2020754">
        <text>- Patient refusal</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2022064">
        <text>- Have a history of alcohol abuse.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2023003">
        <text>- Smokers, alcoholic and drug abusers.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2034041">
        <text>3. Subjects who agree to undergo the any of the following four treatments, including radical prostatectomy, definitive prostate radiotherapy, systemic chemotherapy, and androgen deprivation therapy for prostate cancer.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2036555">
        <text>- Having a score of greater than or equal to 26 on the Mini-Mental State Exam (MMSE)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2037735">
        <text>For both study populations:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2037806">
        <text>- Presence of 4-8 AK lesions total in a 25 cm2 area identified on the face through transparency mapping and photographs. The face area will be defined from hair line to jaw line. The scalp will not be included. An imaginary normal hair line will be the upper boundary for bald men.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2039832">
        <text>- Inability, in the investigator's opinion, to comply with study procedures or assessments</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2040608">
        <text>14. Asthma that needed emergency treatment, hospitalization, oral or intravenous corticosteroid to keep stable in the past two years.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2041098">
        <text>- Prior radiation therapy within the last 4 weeks; prior radiation therapy to indicator lesion (unless objective disease recurrence or progression within the radiation portal has been documented since completion of radiation).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2043549">
        <text>- Hepatic insufficiency (Alanine aminotransferase (ALT) or Aspartate aminotransferase (AST) above 2 times the central laboratory's upper reference limit)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2047090">
        <text>- CC resistant PCOS</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2049413">
        <text>- cognitive impairment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2050206">
        <text>Healthy Participants</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2052028">
        <text>1. number of retrieved oocytes was ≥20</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2052639">
        <text>- Patients on concurrent anticancer therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2054922">
        <text>5. Participation to any investigational drug study &lt; 4 weeks preceding study enrolment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2056758">
        <text>- Patients who are pregnant.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2056785">
        <text>8. Written Informed Consent must be obtained.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2058350">
        <text>- Change of immunomodulatory therapy &lt; 30 days prior to inclusion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2059249">
        <text>- At least 1 of the regimens must have included high-dose dexamethasone (40 mg on days 1-4, 9-12, and 17-20) or medium-dose dexamethasone (40 mg on days 1, 8, 15, and 22) of a 28-day course</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2061066">
        <text>WOCBP had to abstain from sex or they and their partners had to use adequate contraceptive precautions for the duration of the study.</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2062354">
        <text>- Non- consenting</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2076601">
        <text>- Chronic medication which could affect the results of the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2078271">
        <text>- Sensitivity to any of the study medications or any of the ingredients or excipients of these medications</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2079001">
        <text>- subjects with malnutrition, defined as a serum albumin &lt; 3.0 mg/dl, in order to avoid worsening protein-malnutrition status during the restricted study period since phosphate restricted diets are also low in protein</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2086935">
        <text>- Head injury with more than 5 minutes of unconsciousness</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2089941">
        <text>- Stroke</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2090882">
        <text>10. Able and willing to attend scheduled follow-up visits and study related exams.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2092106">
        <text>- Participant who have received intra-articular, intramuscular (into the muscle), or intravenous (into the vein) corticosteroids, including adrenocorticotropic hormone (hormone made by the brain that activates the adrenal glands) within 4 weeks before the first dose of the study medication</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2095677">
        <text>- placement of an intrauterine device (IUD) or intrauterine system (IUS); OR</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2100956">
        <text>- No social security</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2102590">
        <text>- Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1 (APPENDIX A: Performance Status Criteria)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2103258">
        <text>- Ability to send and receive emails</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2104494">
        <text>- Retrolabyrinthine approach</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2104785">
        <text>- Major surgery in the past two weeks</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2104878">
        <text>- Subject has positive serology for HIV 1, HIV 2, HBsAg or HCV.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2105312">
        <text>- Sight and hearing (a hearing aid is permitted) are sufficiently good to allow the undertaking of study-related procedures and psychometric tests.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2106583">
        <text>- No history of other malignancy within the last three years, except for carcinoma in situ of the cervix or basal cell or spinocellular carcinoma of the skin.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2118396">
        <text>- Necessity of planned treatment with other chemotherapeutics oder anti-hormone therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2118868">
        <text>- Prior/concomitant therapy with thienopyridine or daily treatment with nonsteroidal antiinflammatory drugs or cyclooxygenase-2 inhibitors</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2120155">
        <text>- Subject has a positive serology test for hepatitis B surface antigen (HBsAg), hepatitis A virus antibodies (anti-HAV) (immunoglobulin M [IgM]), hepatitis C virus antibodies (anti-HCV), or antibodies to human immunodeficiency virus type 1 (HIV-1) and/or type 2 (HIV-2) at screening.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2122540">
        <text>- Any individual with features of autism who has had genetic testing and a known genetic diagnosis may be eligible to participate; contact the study team for more information.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2124769">
        <text>- 18 years or older</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2125797">
        <text>- HIV positive patients with advanced immune supression and evidence of HIV resistant to all combinations of antiretroviral therapy considered at high risk of non lymphoma related death within 12-months due to other AIDS complications should not be enrolled on the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2126100">
        <text>19. Plasma donation within 7 days prior to Day -1 of Period 1.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2127984">
        <text>10. Any new serious opportunistic infection within the past 6 weeks</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2128081">
        <text>- signature of the written consent</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2133829">
        <text>- Previous bypass operation</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2141627">
        <text>12. Subject has had prior abdominal surgery of the gastrointestinal tract in the last 6 months, other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2144028">
        <text>- Patients with newly diagnosed multiple myeloma, secretory, or oligosecretor or not secretor if it has soft tissue plasmacytomas.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2150276">
        <text>1. Apgar score &lt; 5 at 10 minutes, or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2150718">
        <text>- Patient who do not declined to have his medical records reviewed for research</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2151374">
        <text>- upper respiratory signs or symptoms (rhinorrhea, cough, or pharyngitis) or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2152081">
        <text>2. No period of good functioning in previous 2 years; OR,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2159122">
        <text>- Are postmenopausal for at least 1 year before the screening visit, OR</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2160898">
        <text>3. Be unwilling to comply with the study requirements</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2161936">
        <text>- Presence of cervical lesion pre-invasive or invasive on the cervix *</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2167457">
        <text>- Patients diagnosed with clinical depression</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2168038">
        <text>- Abuse of alcohol (&gt;20 alcoholic consumptions per week)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2171437">
        <text>1. History of lung disease other than asthma (e.g., cystic fibrosis, chronic obstructive pulmonary disease, interstitial lung disease, etc.)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2172363">
        <text>- Myocardial infarction within the previous two (2) months.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2176221">
        <text>- Uncontrolled glucose levels (A1c&gt;9)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2180016">
        <text>- History of psychotic disorders,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2185683">
        <text>- Overtly healthy males or females (Women: contraception, Pearl Index &lt;1%)</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2191374">
        <text>- History or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2192186">
        <text>- Not pregnant</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2193027">
        <text>8. Willing and able to wear a Fitbit wrist-based activity tracker device and an Actigraph device.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2194243">
        <text>- Life expectancy &lt; 3 months.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2195162">
        <text>- Systemic conditions which predispose to Candida specie infection such as uncontrolled diabetes and xerostomia.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2199345">
        <text>3. A male with no congenital or chronic disease in three years, no history of symptoms in internal treatment, or no knowledge in the area</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2204324">
        <text>- Subject disagrees to stop intake of other products containing probiotics during study time.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2207927">
        <text>- Expected lifetime&gt;1 year</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2208535">
        <text>2. Ventilator dependency;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2211147">
        <text>- Case history of antidepressant treatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2212242">
        <text>4. History of percutaneous coronary intervention or coronary artery bypass graft</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2214672">
        <text>- has a history of diabetic ketoacidosis in the last 6 months.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2231053">
        <text>- Verified og suspected other reason than mastectomy/lumpectomy for the pain.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2236959">
        <text>- Phototherapy for AD</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2237555">
        <text>- History of gastro-intestinal ulcer, perforation or bleeding</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2243818">
        <text>- APACHE II score ≥ 10 AND</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2252144">
        <text>- Subject has known allergy against Fe-products or dextranes</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2252606">
        <text>- Life expectancy &gt;= 12 weeks</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2261919">
        <text>- Known or suspected abuse of alcohol or narcotics</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2262006">
        <text>- Singleton pregnancy.</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2265408">
        <text>- Previous treatment with compounds targeting cholesteryl ester transfer protein (CETP)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2265454">
        <text>- Structural heart disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2266669">
        <text>- All patients were ventilated and sedated during an 8-hour period of measurement</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2266828">
        <text>- Age at least 18 years</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2266961">
        <text>- COPD patients with AHRF requiring NIV</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2272086">
        <text>- Malignancies within the last five years, with the exception of adequately treated basal or squamous cell carcinoma of the skin or carcinoma in situ of the cervix.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2276507">
        <text>- Have very poor kidney function.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2281038">
        <text>- Is currently abusing alcohol and/or any other substance</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2283663">
        <text>3. Complex injuries (a combination of posterior and anterior cruciate and lateral ligament injury)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2286265">
        <text>- Healthy male and/or female subjects of non childbearing potential.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2286365">
        <text>- Under the age of 18,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2287684">
        <text>- Patients aged between 7 and 15 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2293298">
        <text>4. Known history of a bilateral mastectomy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2293807">
        <text>19. Pregnancy. Although beetroot juice has not knows teratogenic effects, we feel that not enough data exist in this regard. Therefore, all females patients of reproductive age will be required to undergo a pregnancy test prior to enrollment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2300636">
        <text>3. Inability by one of the investigators to obtain informed consent from the legally authorized representative</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2301851">
        <text>- no previous diagnosis of familial polyposis syndromes</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2306505">
        <text>10. Subjects who are enrolled in any other clinical trial using systemic medication; or any other treatment that might interfere with this study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2307090">
        <text>- Former achilles tendon rupture</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2307623">
        <text>- Japanese</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2313711">
        <text>13. Subjects who, through completion of this study, would have donated and/or lost more than 400 mL of blood in past 2 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2314486">
        <text>- Known hypersensitivity to any of the study drugs or excipients.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2317413">
        <text>4. Sustained ventricular tachycardia (VT) or ventricular fibrillation (V-fib) within 14 days of screening.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2318342">
        <text>7. Any condition associated with increased risk of metformin hydrochloride-associated lactic acidosis (e.g. congestive heart failure defines as NYHA class III or IV, history of any type of acidosis, habitual intake of ≥ 4 alcoholic beverages per day)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2319573">
        <text>- Relapsed after prior autologous SCT</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2322228">
        <text>- Self report of illicit drug use (except marijuana) in the past. Use of marijuana during the last 3 month...</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2323299">
        <text>- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2323394">
        <text>- Infants born prematurely, as defined by birth at less than 37 weeks gestational age, referred for a videofluoroscopic swallow study (VFSS) due to suspected pharyngeal phase dysphagia.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2325879">
        <text>- Major surgery within 30 days or anticipated or planned major surgery during the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2332002">
        <text>22. Patients must give written consent.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2335735">
        <text>- Patients who identified their predominant symptom as heartburn and were classifiend as Grande M or N according to Hoshihara's modofied version of Los Angeles Classification at esophagogastroduodenoscopy. Written informed consent, ability to comply with study instructions</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2336172">
        <text>- Ongoing antibiotic treatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2341648">
        <text>- Subjects who are required to spend excessive time in the sun (i.e. lifeguards, other outdoor workers).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2344025">
        <text>- Before patient registration, written informed consent must be given according to ICH/GCP, and national regulations.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2351210">
        <text>- History of drug or alcohol abuse.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2351891">
        <text>- Myocardial infarction documented as a clinical diagnosis or by EKG or any other test</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2357084">
        <text>10. Patients taking didanosine, azathioprine, or nucleoside reverse transcriptase inhibitors</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2357648">
        <text>- Endoscopic appearance of invasive malignancy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2359262">
        <text>- History of panretinal photocoagulation or macular laser photocoagulation in the study eye.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2362144">
        <text>- History or evidence of habitual use of tobacco- or nicotine-containing products within 3 months of screening.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2373215">
        <text>- History of hypersensitivity to a previous dose of influenza vaccine.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2374575">
        <text>- Phakic study eye</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2375545">
        <text>- Radiographic evidence suggestive of any of these infections is sufficient grounds for exclusion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2378481">
        <text>- Drug interactions with any of the study drugs that are not manageable</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2379324">
        <text>4. Participants with unstable or active cardiovascular illnesses (myocardial infarction, CHF, etc), active or end-stage renal disease, unstable thyroid disease, etc.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2381864">
        <text>- French participants: In France, a subject will be eligible for inclusion in this study only if either affiliated to or a beneficiary of a social security category.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2386481">
        <text>- PCI or CABG in last 3 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2388112">
        <text>3. Intracranial hemorrhage within last 3 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2394277">
        <text>- Prior allogeneic stem cell transplantation within 2 months of trial enrollment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2399095">
        <text>- Smoking ≥ 15 cigarettes daily</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2399518">
        <text>- AML evolving from MPD and/or secondary AML</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2400894">
        <text>- rash or arthropathy suggestive of scarlet fever</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2401121">
        <text>- Rheumatoid arthritis diagnostic according to the American College Rheumatology (ACR) 1987 criteria [38]</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2404155">
        <text>- Fluent in reading and speaking English and have a reliable study partner (caregiver) (someone who is in frequent contact and can make sure study medication is being taken correctly).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2404766">
        <text>- A stable sleep/wake pattern with a normal phase relationship to the environment and no history of sleep disorders</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2409984">
        <text>- severe pulmonary hypertension or use of pulmonary hypertension drugs (such as sildenafil, bosentan or other endothelin inhibitors)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2411647">
        <text>- Unwillingness to participate.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2414344">
        <text>- Age: less than 80 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2414531">
        <text>1. A history or presence of significant cardiovascular (including thromboembolic disorders), neurological, hematological, psychiatric, hepatic, gastrointestinal, pulmonary, endocrine, immunologic or renal disease or other condition known to interfere with the absorption, distribution, metabolism, or excretion of drugs or place the subjects at increased risk as determined by the investigator.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2419554">
        <text>5. Non-cooperative subjects.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2427523">
        <text>- Human Leukocyte Antigen (HLA) B27 positivity</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2429058">
        <text>- Able to take and retain oral medications</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2433411">
        <text>- Smokers group:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2441559">
        <text>23. Subjects taking medications on specified hourly intervals that may be affected by changes to gastric emptying</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2442010">
        <text>- Healthy as determined by a responsible and experienced physician, based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring. A subject with a clinical abnormality or laboratory parameters outside the reference range for the population being studied may be included only if the Investigator and the GSK Medical Monitor agree that the finding is unlikely to introduce additional risk factors and will not interfere with the study procedures. Subjects with blood pressure values outside the normal range [systolic (90-139 mmHg) and diastolic (50-89 mmHg)] and subjects with ECG findings suggestive of a previous MI should always be excluded from enrollment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2444001">
        <text>- Failure to culture until Day 5</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2444074">
        <text>21. Concomitant administration of any medications known to affect blood pressure, except medications allowed by the protocol</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2444857">
        <text>- Willingness to track medications, relaxation techniques and number of case manager visit</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2450258">
        <text>- ALT over N and HCV RNA+ at screening</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2450771">
        <text>1. Reported at least a 1-year history of regularly experiencing PMDD.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2452952">
        <text>- Males or females between 18 and 45 years, inclusive.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2458412">
        <text>4. Patient has fibroids confirmed by MRI</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2458863">
        <text>- Women who have been diagnosed to have a fetus with a chromosomal or structural fetal anomaly and do not plan to continue their pregnancy</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2459104">
        <text>- Patients needing diathermy treatment;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2462504">
        <text>- Cataract</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2463540">
        <text>- partial seizures with or without secondary generalization</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2463916">
        <text>- Active bowels inflammatory disease (Crhon, chronic, diarrhea...)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2471411">
        <text>- National Institutes of Health Stroke Scale (NIHSS) score greater than 4</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2474451">
        <text>- Must have a history of mild to moderate hypertension (140-179 systolic; 90-1-9 diastolic).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2475475">
        <text>- ADHD identified as primary reason for seeking treatment at phone screen</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2477133">
        <text>- Diagnosis of severe osteoporosis/penia as proven with pQCT or DXA.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2485960">
        <text>- presence of clinically relevant fibroids that cannot be treated for technical reasons</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2499164">
        <text>- Age &gt;= 18</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2506309">
        <text>- Women who are pregnant or breast feeding</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2517254">
        <text>2. Patients with previous history of extranodal lymphoma.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2517916">
        <text>- Any other concurrent severe known disease (except carcinoma in-situ) or concurrent severe and/or uncontrolled medical condition (e.g. uncontrolled diabetes, or active uncontrolled infection) which could compromise participation in the study</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2519637">
        <text>- Preoperative chemotherapy or hormone therapy for local relapse</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2519710">
        <text>- Presence of at least moderate symptom severity measured according to the PANSS (score of at least 75)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2520136">
        <text>- Signed informed consent,</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2520700">
        <text>- PR ≥210 msec</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2521634">
        <text>- Bulbar dysfunction</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2523494">
        <text>- Body weight:55-90kg, BMI:18.0-27.0</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2524249">
        <text>- Platelet count less than 50 per microliter (current admission)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2536321">
        <text>1. Inability to sign written informed consent.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2537725">
        <text>4. Congestive heart failure of NYHA class 2 or worse</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2538626">
        <text>- History of malignancy, except basal or squamous cell skin carcinoma.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2539106">
        <text>- initiated ART other than PMTCT prior to enrollment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2539185">
        <text>4. Untreated proliferative diabetic retinopathy.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2540775">
        <text>- 3 vials 1.0 x 10^7/mL mononuclear peripheral blood cells</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2547812">
        <text>Inclusion Criteria for obese subjects:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2548180">
        <text>- Age younger than 18 or older than 80 years, socio-pathology or inability to understand the study objectives</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2551701">
        <text>- Men and women, ages ≥ 18 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2556700">
        <text>- Treatment: osteoporosis medication.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2557838">
        <text>- Permanent, refractory atrial fibrillation treated with atrio-ventricular node ablation and biventricular pacing</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2563712">
        <text>- Current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2568089">
        <text>- Patient has a prostate size of at least 25 ml and not more than 80 ml, measured by ultrasound</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2568397">
        <text>- Individuals with jobs which require night-time shift work.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2568402">
        <text>- AD (DSM-IV)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2575585">
        <text>3. Active bleeding</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2576942">
        <text>10. Patients with the ability to understand and give written informed consent for participation in this trial, including all evaluations and procedures as specified by this protocol.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2578682">
        <text>- Patient is ≥ 18 years old at the time of the drug administration</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2579306">
        <text>4. Subject is scheduled to undergo one of the surgical procedures described above</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2591183">
        <text>- Stable diet and exercise routine</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2596778">
        <text>- Unstable patient conditions as daily variability of the blood arterial pressure &gt;20%, arrhythmias, PaO2/FiO2 &lt; 300, unsatisfactory respiratory pattern, haemoglobin &lt; 7 g /dL, temperature &gt; 38°C, presence of neurological or orthopaedic side effects, and recent embolisms from TVP. Refusal.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2598647">
        <text>- Active and ongoing steroid use, except for non-systemically absorbed treatments (such as inhaled or topical steroid therapy for asthma, COPD, allergic rhinitis).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2602914">
        <text>- Altered sensation at baseline reported as numbness or unusual feeling.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2602964">
        <text>- Ability and willingness of volunteer to provide written informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2603180">
        <text>- left ventricular assist device</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2603610">
        <text>1. Hb &lt;4.0 g/dL</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2605296">
        <text>- currently on continuous positive airway pressure (CPAP) or on CPAP during the last 3 months before stroke</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2606844">
        <text>- Recipients and donors willing to be recruited as a pair to this study</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2607416">
        <text>- Histologic confirmation of intrinsic brain stem tumors not required</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2624178">
        <text>- severe aortic stenosis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2630682">
        <text>- Treatment with insulin</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2631982">
        <text>5. Family is unlikely to be available for long-term follow-up</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2644144">
        <text>- Patients who have had a respiratory tract infection.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2644605">
        <text>- Significant heart involvement (due to Chagas disease)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2653225">
        <text>Allergy to antiplatelet drugs, heparin, stainless steel, contrast agents, sirolimus, or paclitaxel; participation in another coronary-device study; and terminal illness.</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2654798">
        <text>- Patients with controlled systemic disease for &gt;6 weeks (as judged on a case by case situation)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2656383">
        <text>7. Known hypersensitivity to drugs of the same class as the study treatment, or any excipients of the drug formulation.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2659220">
        <text>4. any patient who has undergone prior excisional biopsy of their primary breast tumor must have had margins positive for disease, or must have either mammographic or ultrasonographic evidence of probable residual disease in the breast.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2664445">
        <text>- patient is on a stable medication regimen (including beta blockers) for at least 4 weeks prior to enrollment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2665214">
        <text>- Symptomatic urinary tract infection at inclusion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2670242">
        <text>- Creatinine =&lt; 2.0 x ULN</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2672375">
        <text>- Pregnant or breast feeding.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2673089">
        <text>- Child-Pugh Class A or B</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2675371">
        <text>- Large foci or clusters of blasts in bone marrow biopsy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2677733">
        <text>- Women who have completed 12 months of active treatment in study M01-391 and Month 12 visit procedures Or completed 18 months of active treatment in study C03-062 and Month 18 visit procedures (with no more than a 14-day interruption in dosing from study C02-062 and this study) OR could not continue in a previous asoprisnil study, but are now eligible for retreatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2679516">
        <text>- History of, diagnosed or suspected genital or other malignancy (excluding treated squamous cell carcinoma of the skin), and untreated cervical dysplasia.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2680510">
        <text>- No evidence of metabolic disease (hypothyroidism, uncontrolled diabetes [hemoglobin A1c &gt;10% within the past 6 months], electrolyte imbalance).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2683561">
        <text>- Clinical spinal cord compression</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2684168">
        <text>- age greater than 18 years</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2688167">
        <text>- ≥1 poorly-controlled CVD risk factor (either HbA1c≥8.0% or SBP≥140 mmHg or LDL≥130 mg/dl), irrespective of medications used</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2692964">
        <text>- Life expectancy of any member in the family is shorter than 6 months in doctor's opinion</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2695963">
        <text>1. An acute infection requiring ongoing antibiotic therapy (e.g., UTI, indwelling catheter or other potential site(s) of infection)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2697102">
        <text>4. Intractable severe diarrhea.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2697359">
        <text>- missing informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2700283">
        <text>- Blood products within 56 days prior to study vaccination.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2705366">
        <text>- With a cartilage lesion identified during MRI and either at least 1 out of 4 MRI severity criteria:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2707854">
        <text>NHL previously untreated with cytotoxic chemotherapy; however, patients may be entered if they have had prior cyclophosphamide for an urgent problem at diagnosis (e.g. epidural cord compression, superior vena cava syndrome) and/or a single dose of intrathecal methotrexte (MTX) at the time of the pre-treatment diagnostic lumbar puncture</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2709236">
        <text>4. Prospective participants or their legal guardians who, based on the judgment of the team, appear to have impaired ability to understand and appropriately use complex medical and genetic information, or to cope with potentially life altering medical information, will be ineligible.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2710629">
        <text>- Measurable or evaluable disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2720544">
        <text>3. Myopathy, history of rhabdomyolysis or myopathy due to statins or fibrates, or elevated CK level ≥ 5 x upper limit of normal (ULN) during the previous statin treatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2721805">
        <text>Pulmonary function: DLCO corrected for hemoglobin and alveolar volume greater than or equal to 50% of predicted.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2725995">
        <text>3. Currently using nicotine replacement therapies or other pharmacotherapies as cessation aid (non-cessation intermittent use acceptable)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2729340">
        <text>- Preterm neonates.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2733243">
        <text>2. More than 7 alcoholic drinks a week for females or 14 alcoholic drinks a week for males.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2733872">
        <text>- Have had HIV-1 vaccines in a clinical study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2737994">
        <text>- Patients not treated adequately for soil-transmitted helminthic diseases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2741594">
        <text>- ability to write and read properly in Hebrew</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2745721">
        <text>- not receiving BP-lowering medication.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2760708">
        <text>1. Good general health</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2763001">
        <text>- All subjects/patients must sign an Informed Consent Form prior to participation in the trial in accordance with ICH-GCP and the local legislation, i.e., the COPD patients must give written informed consent prior to pre-study washout of their usual pulmonary medications.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2769104">
        <text>- Recent tooth extraction or major dental procedure within 3 weeks of study entry</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2769953">
        <text>- Refused chemotherapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2770554">
        <text>- Tumor markers</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2773204">
        <text>- Body Mass Index ≥ 35.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2778838">
        <text>4. current or recent respiratory infection (within the last 4 weeks)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2779028">
        <text>6. Eastern Cooperative Oncology Group(ECOG) Performance Status 0-1</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2782296">
        <text>- Subject has an HbA1C value between 7.5 and 10.0% at Visit 2 and the difference of HbA1C value within ± 1.0% between Visit 1 and Visit 2</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2784069">
        <text>- A recognised significant co-existing respiratory disease, defined as a respiratory condition that exhibits a clinically relevant effect on respiratory symptoms and disease progression as determined by the principal investigator following multi-disciplinary discussion. For example, patients with bronchiectasis will only be included if the bronchiectasis is deemed to be traction bronchiectasis as a result of idiopathic pulmonary fibrosis.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2784160">
        <text>- Breast feeding infants whose mothers are taking acyclovir, valacyclovir, or famciclovir for &gt;120 hours (&gt;5 days). If at any point following enrollment the mother takes these antiviral drugs for &gt;120 hours (&gt;5 days), she will be asked to refrain from breast feeding while taking the drug.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2786282">
        <text>- Patients undergoing therapeutic upper endoscopy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2786530">
        <text>Subjects belonging to one of the following groups will be excluded from the study:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2788084">
        <text>Direct bilirubin more than or equal to 2 times ULN.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2790651">
        <text>7. Eating disorder</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2797456">
        <text>- Triglycerides ≥ 150 mg/d.l</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2805379">
        <text>Free of acute and chronic diseases (especially GI disorders) as determined by medical history, physical examination and laboratory tests.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2810403">
        <text>- Women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before CT</text>
        <comments>
          <comment>
            <text>auto pregnancy</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2812325">
        <text>- some artificial heart valves</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2813640">
        <text>12. Impairment of gastrointestinal (GI) function, or a GI disease that may significantly alter the absorption of study drugs (e.g. rare hereditary problems of galactose intolerance , the Lapp lactase deficiency or glucose-galactose malabsorption, severe malabsorption syndrome, or extended small bowel resection).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2816499">
        <text>- myopia &gt;6.0 D</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2816782">
        <text>- Be currently taking 1 to 3 AEDs.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2829437">
        <text>- Current alcohol dependence</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2833166">
        <text>7. History of urinary retention</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2838965">
        <text>Healthy volunteers will be eligible for the study if they are:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2847031">
        <text>20. Be serum positive for HIV, hepatitis BsAg or viremic hepatitis C.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2847638">
        <text>- Bone disease</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2849393">
        <text>2. Women of childbearing potential (WOCBP=premenopausal woman capable of becoming pregnant) must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) within 24 hours prior to the start of study drug.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2853595">
        <text>- Results of complementary laboratorial exams outside the values considered normal according to this protocol rules, unless they are considered non-clinically significant by the researcher.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2855265">
        <text>- Admitted for respiratory failure primarily due to COPD exacerbation</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2855605">
        <text>- ≥ 50 years of age</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2859460">
        <text>Group A: ART naïve or if ART-exposed, has not received HAART for at least the six months prior to study entry Group B: Has been receiving HAART for at least six months at the time of study entry, with two HIV-1 RNA plasma viral loads &lt; 400 copies/ml on two previous clinical visits within the 6 months prior to study entry</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2861148">
        <text>- patients undergoing elective repair, willing/able to undertake a period of prehabilitation, and those able to comprehend and retain instructions regarding self-training.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2870636">
        <text>- Male and female patients with a diagnosis of short bowel syndrome (as defined by surgical therapy for congenital or acquired gastrointestinal disease) between the ages of 1-17</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2873596">
        <text>The Evaluator must be:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2876517">
        <text>6. Any previous treatment with a Programmed Cell Death Protein 1 (PD1) or PD-L1 inhibitor, including durvalumab.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2885467">
        <text>Males or females aged ≥18 years, &lt; 75 years. Eastern Cooperative Oncology Group (ECOG) performance status 0-3. Life expectancy ≥12 weeks. Ability to maintain a drainage catheter. Previous intrapleural administration of chemotherapeutic drugs (preferred bleomycin) Males and females should be contraceptive during the period of the trial until 8 weeks after the last administration of the drug.</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2889073">
        <text>- Abdominal / Thoracic Surgery (excl appendectomy or cholecystectomy)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2890161">
        <text>- Nephropathy (serum creatinine &gt;150 µM and/or albuminuria</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2891576">
        <text>- Known resistance to &gt;2 classes of ART</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2899672">
        <text>- ER+ve or ER-ve</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2900979">
        <text>- Cardiac pacemakers, implanted medication pumps, intracardiac lines</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2901744">
        <text>6. has not recovered to grade 1 or better from any adverse events related to previous therapy.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2901988">
        <text>- Delayed gastric emptying syndrome</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2903174">
        <text>- chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs [except for therapeutic maintenance dosage of aspirin], antibiotics, steroid inhalers, etc.)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2903568">
        <text>- experienced in the care of community children</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2903644">
        <text>- Prior treatment with rociletinib, or other drugs that target T790M positive mutant EGFR with sparing of wild type EGFR</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2916264">
        <text>- No unstable angina pectoris within the past 6 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2934026">
        <text>- Subjects who had previously entered into this study or simultaneously participated in another clinical drug trial</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2934601">
        <text>- no distant metastases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2937366">
        <text>6. Presence of severe renal disease (BUN 50% greater than normal or creatine clearance &lt;60 mL/min) or hepatic disease.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2937445">
        <text>- History of revascularization(PCI, CABG) or prior diagnosis of myocardial infarction</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2941189">
        <text>9. Patient or patient's legal representative has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as notified / approved by the Institutional Review Board/Ethics Committee of the clinical site.</text>
        <comments>
          <comment>
            <text>auto Will</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2951802">
        <text>- Laser photocoagulation (panretinal or macular) in the study within 90 days of baseline</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2952727">
        <text>1. Patient age at surgery is 12-35.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2953403">
        <text>- high risk for an acute cardiovascular event</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2955102">
        <text>- Grade III/IV diarrhea in the screening period.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2956214">
        <text>- Patients who have received any investigational (unlicensed) drugs within the last 3 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2959596">
        <text>- Subject does not have a history of any bleeding disorder</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2965813">
        <text>- Able and willing to provide informed consent</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2966512">
        <text>equivalent) or other immunosuppressive medications within 14 days of first treatment.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2966938">
        <text>- recent cardiovascular diseases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2970223">
        <text>- completion of basic education (former 4th primary series).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2977565">
        <text>16. Axial myopia of greater than -8 diopters in the eye that is to be implanted</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2977584">
        <text>- Presence of anatomical abnormalities in the neck or pharyngeal region (such as enlarged tonsils)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2977620">
        <text>- Inability to take and absorb orally administered medication.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2981863">
        <text>- Use of any drugs known to induce or inhibit hepatic drug metabolism (examples of inducers: barbiturates, carbamazepine, phenytoin, glucocorticoids, rifampin/rifabutin; examples of inhibitors: antidepressants, cimetidine, diltiazem, erythromycin, ketoconazole, MAO inhibitors, neuroleptics, verapamil, quinidine), use of an investigational drug or participation in an investigational study within 30 days prior to administration of the study medication.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2984052">
        <text>2. Nuclear sclerosis: upto grade 3</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2984079">
        <text>8. Subject has left ventricular ejection fraction ≥50%.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2985322">
        <text>- Subject mentioned in articles L1121-5 to L1121-8 of "code de la santé publique"</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="2994552">
        <text>- 8.0 g/dl</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="2996183">
        <text>- Patients with a documented history of HIV, active hepatitis B or C infections</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3000170">
        <text>- Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3002721">
        <text>1. Patients had non-plaque (i.e., pustular, guttate, or erythrodermic) or drug-induced forms of psoriasis, total body surface involvement of more than 60%</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3010204">
        <text>- dementia,</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3020160">
        <text>- Age-related macular degeneration</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3024168">
        <text>- Uncontrolled hypertension (i.e., SBP &gt; 170 mm Hg or DBP &gt; 110 mm Hg)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3024758">
        <text>12. Any condition which, in the opinion of the investigator, would interfere with the evaluation of the vaccine or pose a health risk to the subject.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3028992">
        <text>- Patient judged inappropriate for randomization due to other condition requiring chronic thienopyridine use.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3031683">
        <text>- oral steroid use</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3033298">
        <text>- meet standard NIH eligibility criteria for bariatric surgery</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3033807">
        <text>14. Patients with a history of severe hypersensitivity reaction to compounds of similar chemical or biologic composition to carboplatin, paclitaxel, bevacizumab or other agents used in the study.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3035159">
        <text>- Trauma with vision loss</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3038858">
        <text>- Any other hormone treatment contraindications;</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3039492">
        <text>- The patient has any clinically significant uncontrolled medical condition, treated or untreated.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3039947">
        <text>- Creatinine clearance &lt; 30 ml/min</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3040215">
        <text>- Male and female participants 15 years of age and above.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3041779">
        <text>7. Fifteen patients who are 1 month to-12 months of natalizumab therapy, fifteen patients who are 24 months and over of natalizumab therapy will be asked to participate in the TNF alpha subset.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3042767">
        <text>- Pregnant or nursing women</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3046474">
        <text>- BMI 20 to 27 kg/m2</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3050464">
        <text>3. Inability to obtain informed consent from the patient or a health care proxy.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3055489">
        <text>- GCS of 3 with bilaterally fixed and dilated pupils</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3057612">
        <text>- Grade 3 histology</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3058013">
        <text>- high LDL cholesterol (≥ 130 mg/dL and &lt; 190 mg/dL), on statin therapy or not</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3058314">
        <text>- Received a blood transfusion or blood products within 6 months to first dose</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3067188">
        <text>- Inability to return for follow up appointments at 3 and 6 weeks</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3070260">
        <text>- Nodule must be discovered at the time of diagnosis of the primary malignancy or after the completion of therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3072966">
        <text>- Response must be confirmed to be stable between the end of the previous therapy and the initiation of the trial (see the time that must elapse in the previous criteria).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3075082">
        <text>- Onset of MS symptoms occurring within 90 days of randomization</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3076264">
        <text>- Low-risk prostate cancer after curative therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3078723">
        <text>8. Lactose intolerance</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3078909">
        <text>- Patients should not be on antibiotics for any infection but post operative antibiotics are allowed if used prophylactically but should be completed prior to starting RT.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3081109">
        <text>- History of regular alcohol consumption exceeding, on average, 14 drinks/week (1 drink = 150 mL of wine or 350 mL of beer or 45 mL of 80 proof distilled spirits) within 6 months of screening</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3083883">
        <text>- Female patients of childbearing potential unwilling to use a medically acceptable form of contraception (i.e., hormonal birth control, intrauterine device [IUD], double barrier [male condom or female condom with a diaphragm], or a barrier method plus a spermicidal agent [contraceptive foam, jelly, or cream]) Female patients are considered to be of childbearing potential unless they have been postmenopausal for at least 1 year, are biologically sterile, or are surgically sterile (history of hysterectomy, bilateral oophorectomy, or bilateral tubal ligation.</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3094694">
        <text>- history of hypersensitivity to compounds of similar chemical or biologic composition to the antibody women how are pregnant or breastfeeding</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3105226">
        <text>- Subjects with history or known presence of gastrointestinal bleeding.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3107646">
        <text>- sign an informed consent agreement.</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3121925">
        <text>- history of or current inflammatory joint disease other than RA</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3133800">
        <text>- ECOG performance status less than or equal to 2 (Karnofsky &gt;60%).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3140586">
        <text>- Hemoglobin &lt;9 g/dL</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3142931">
        <text>- without physical complications that prevent the execution of physical exercises</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3143298">
        <text>- A positive test for Human Immunodeficiency Virus (HIV) antibody.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3144224">
        <text>- Patients at least 18 years of age at the time of informed consent (women of childbearing potential must be practicing adequate contraception)</text>
        <comments>
          <comment>
            <text>auto contraception</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3146986">
        <text>- Previous history of allergic reactions to the products used in the bat</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3147482">
        <text>- ability to walk independently or assisted or move unassisted in a wheelchair</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3148967">
        <text>- Clinics were the intervention was only partially implemented</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3154383">
        <text>- infertile females with preserved gonadal function</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3155646">
        <text>- Sensory neuropathy (&gt; CTCAE Grade 1), unresolved toxicity &gt; CTCAE Grade 1 attributed to any prior therapy/procedure excluding alopecia</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3165721">
        <text>- severe diseases</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3165737">
        <text>- Patients with history of hypersensitivity to α receptor blockers, a/b receptor blockers, or anticholinergic drugs</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3172380">
        <text>- The guardian or child (in a developmentally-appropriate manner) do not understand the study procedures. This will be verified by asking both guardian and child (if 6 years old or older) to repeat the study procedures.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3174561">
        <text>- Occupation as a flight attendant for at least 5 years prior to the smoking ban on commercial aircraft.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3175892">
        <text>iii) Has had a bilateral tubal ligation, or</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3180048">
        <text>- Pregnant or nursing women;</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3181065">
        <text>- Female patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained. Lactating females are not eligible unless they have agreed not to breastfeed their infants for the duration of protocol therapy. Sexually active patients of reproductive potential are not eligible unless they have agreed to use an effective contraceptive method for the duration of protocol therapy.</text>
        <comments>
          <comment>
            <text>auto contraceptive</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3181223">
        <text>- Patients with short-gut syndrome or a serum albumin less than 32 g/L</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3182811">
        <text>- Cardiac insufficiency or high blood pressure without controlled</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3183098">
        <text>- Patients 18-70 years old having a planned laparoscopic surgery with an umbilical first trocar at CHUS were included.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3185347">
        <text>- known cow's milk allergy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3187381">
        <text>2. Age 18 years or older</text>
        <comments>
          <comment>
            <text>auto</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>answerable</tag>
          <tag>temporal</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3188125">
        <text>- Known infection with HIV, hepatitis B, or hepatitis C</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3190447">
        <text>- The participant has ongoing side effects ≥ Grade 2 due to prior anticancer therapy</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3192147">
        <text>3. Serum ferritin &gt; 15 mcg/L</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3197413">
        <text>2. Patients who are older than 20 years at the time of consent</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3197507">
        <text>- Unable to sign consent form</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3197741">
        <text>- Patients who have abnormalities of the uterus</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3204562">
        <text>7. Any of severe comorbid medical conditions according to ASA score ≥ 3</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3208808">
        <text>- male partner with normal semen analysis according to world health organization (WHO) 2010.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3209272">
        <text>7. If female, must be neither pregnant nor breast-feeding and must lack childbearing potential for the duration of the study.</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3211150">
        <text>4. pregnant or nursing</text>
        <comments>
          <comment>
            <text>auto pregnant</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3215831">
        <text>- Recent (within last month) or current intensive MLD and/or short stretch bandage use</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3216261">
        <text>Arthroplasty present infection</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3218631">
        <text>- Current use of warfarin (patients will be eligible if warfarin is discontinued and low-molecular weight heparin is used instead).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3227237">
        <text>- BMI &lt;30 kg/m2 (due to limited MR diameter)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3230726">
        <text>Participants must meet all inclusion criteria, verified by medical evaluation, psychological evaluation, and review of medical history. Inclusion criteria include:</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3234335">
        <text>- Informed consent signed by the patient</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3237608">
        <text>5. At the discretion of the PI, concomitant medications will be permitted if the following conditions are met prior to baseline assessment (Day-1):</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3238233">
        <text>- Uncontrolled psychiatric disorders, such as major depression or psychosis</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3240747">
        <text>- Must be able to understand and give written informed consent and comply with study procedures</text>
        <comments>
          <comment>
            <text>auto informed consent</text>
            <user>walter.forkel@tu-dresden.de</user>
          </comment>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3258439">
        <text>4. Poorly controlled arterial hypertension (SBP ≥ 160mmHg or DBP ≥ 100mmHg) with standard treatment</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3259522">
        <text>- Subject has received rifampin within 4 days prior to first dose of study drug in Arm A (ABT-263 and erlotinib) or Arm C (ABT-263 Monotherapy) and within 7 days prior to first dose of study drug in Arm B (ABT-263 and irinotecan).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3259677">
        <text>4. Patients with Her2/neu overexpression or amplification will be allowed but will be informed about other available treatment options such as lapatinib plus capecitabine.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3260143">
        <text>- Clinical Stage ≥T3 disease, as determined by standard digital rectal examination (DRE)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3261110">
        <text>4. Primary tumors developed 5 years previous to the inclusion, except in situ cervix carcinoma or skin basocellular cancer properly treated</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3264414">
        <text>- planned SIT against wasp venom or finished 5 years SIT against wsp venom (10/10)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3268582">
        <text>- Men or women aged 18 - 50 years (healthy subjects) or greater than 55 years old (subjects with Alzheimer's Disease)</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3269576">
        <text>- Other medical condition likely to cause death within 24 months</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3270419">
        <text>6. Requiring therapeutic anti-coagulant therapy (prophylactic dose of heparin or low molecular weight heparin is allowed).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3271512">
        <text>- Additional inclusion criteria apply</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3271755">
        <text>- Histological confirmation of adenocarcinoma of the prostate with the Gleason score reported (Radical Prostatectomy specimen).</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="inclusion" id="3273316">
        <text>- b.UACR between 100 and 3000 mg/g as determined at the initial Screening visit or by the mean of the 2 morning void urine specimens obtained prior to the second Screening visit.</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>inclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3275101">
        <text>- Being in exclusion on the National Volunteers Data file</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
      <criterion type="exclusion" id="3284100">
        <text>14. Patients with diverticulitis, intra-abdominal abscess, or GI obstruction</text>
        <comments>
        </comments>
        <tags>
          <tag>rand1</tag>
          <tag>not taggable</tag>
          <tag>not answerable</tag>
          <tag>exclusion</tag>
        </tags>
      </criterion>
    </criteria>
  </study>
</studies>
